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ABSTRACT 
 
 
 
Steiner, Jennifer Leah. Ph.D., Purdue University, August 2013. Assessing the Efficacy of 
Acceptance and Commitment Therapy in Reducing Schema-enmeshment in  
Fibromyalgia Syndrome. Major Professor: Silvia M. Bigatti. 
 
 
 
The presence of a chronic pain condition can have a profound impact on one’s 
self-concept.  Some individuals may have had to make major lifestyle changes.  As a 
result, some people may start to define themselves in terms of their pain, such that their 
self-schema and pain-schemas become intertwined in a process termed schema-
enmeshment.  It is thought that schema-enmeshment is related to psychological distress 
making it a prime target for intervention. Little research has been conducted on 
interventions to reduce schema-enmeshment.  Acceptance-based interventions may be 
especially appropriate in reducing schema-enmeshment or the connection between self 
and illness symptoms as these interventions tend to emphasize learning to live with pain 
and other symptoms and to work toward important life goals rather than continually 
fighting against the condition and allowing it to control their life.  This study is a 
randomized trial comparing Acceptance and Commitment Therapy (ACT) to education 
about pain management in a sample of women with Fibromyalgia Syndrome (FMS).  The 
primary aim of this study was to assess the efficacy of ACT in reducing schema-
enmeshment between self and pain, as well as enmeshment between self and other
 xi 
symptoms and FMS as a whole.  In addition, this study also explored the role of pain 
acceptance, specifically activity engagement as a mediator of the relationship between 
treatment group membership and changes in schema-enmeshment.  The data was 
analyzed as an intent-to-treat analysis using the “last measure carried forward” method.  
Results indicated that the ACT group reported statistically significant differences in self 
schema-enmeshment with FMS, fatigue, and cognitive symptoms, but not with pain, 
following the intervention, compared to the educational control group.  In each of these 
cases, the ACT group experienced greater reductions in schema-enmeshment compared 
to the education group.  Interestingly, no statistically significant differences were 
observed for schema-enmeshment with pain.  Statistically significant group differences 
were also observed for acceptance of pain following the intervention.  Finally, a 
mediational model in which changes in activity engagement (a form of pain acceptance) 
served as the mediator of the relationship between treatment group and changes in 
schema-enmeshment with FMS was tested. The model was tested using a bootstrapping 
method, and results revealed a trend toward a significant indirect effect of changes in 
activity engagement leading to changes in schema-enmeshment with FMS.  Taken 
together, the results of this study indicate that ACT may be a promising intervention for 
targeting maladaptive beliefs about the self in relation to illness, especially schema-
enmeshment of self with illness and illness symptoms.  Additionally, there is evidence   
 xii 
that ACT may target key constructs such as activity engagement, which may be related 
to other cognitive and behavioral changes.  Future directions for research and clinical 
practice related to ACT as an intervention for FMS are discussed in depth.
 1 
INTRODUCTION 
 
 
 
Fibromyalgia Syndrome (FMS) is a chronic, painful rheumatic condition for 
which there is currently no biological marker (Wolfe et al., 1995).  FMS is characterized 
by recurrent musculoskeletal pain, fatigue, and nonrestorative sleep.  The condition 
affects approximately 2-7% of the general population and is more common among 
women over the age of 40 (Wolfe et al., 1995).  Because of the lack of a biological 
mechanism for diagnosis, FMS is currently diagnosed based on the presence of “tender 
points”.  Tender points are small regions on the body that are sensitive or “tender” to the 
touch when pressure is applied. There are 18 specific tender points located throughout the 
body that are used to diagnose the syndrome.  In order for an individual to receive a 
diagnosis of FMS, a rheumatologist must identify at least 11 painful tender points across 
several regions of the body (Wolfe et al., 1990).  Due in part to the subjective nature of 
diagnosing this condition, patients with FMS often do not receive validation of their pain 
from those around them; women who suffer from this condition may feel isolated or 
rejected by society (Turk, 2002).  For many years FMS was not even considered a true 
condition.  However, the pain is very real and people with FMS are frequently 
hypersensitive to touch or tactile stimuli (Desmeules, Cadraschi, Rapiti, Finckh, Cohen, 
Dayer, & Vischer, 2004).  This hypersensitivity can make simple actions like shaking 
hands or hugging very painful and may deter these interactions.  
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Possibly related to these factors, the prevalence of depression among individuals 
with FMS is significantly higher than the rates of depression among individuals with 
neuropathic pain  (7.1% vs 3.1%  respectively in Gormsen, Rosenberg, Bach, & Jensen, 
2010), various rheumatic diseases (40% vs 8% respectively in Kurdland, Coyle, Winkler, 
& Zable, 2006) and other pain conditions (Hudson, Hudson, Pliner, Goldenberg, & Pope, 
1985; Walker et al., 1997), although as these studies show, prevalence across FMS 
samples varies widely.  Prevalence rates for depression in FMS as high as 88.2% have 
been reported when both major depressive disorder and atypical depressed episodes are 
included (Ross, Jones, Ward, Wood, & Bennett, 2010).   
Additionally, psychological factors may in turn exacerbate the symptoms of the 
condition.  Symptoms of depression have been found to contribute to an increase in pain 
intensity in patients with FMS (Hasset, Cone, Patella, & Sigal, 2000).  Similarly, research 
has linked pain increases to an individual’s beliefs about the ability to control health 
outcomes (Gustafsson & Gaston-Johansson, 1996) and to the fear of physical activity 
(Turk, Robinson, & Burwinkle, 2004), both of which have been found in patients with 
FMS.  While there is sufficient evidence that psychological factors have an impact on the 
physical outcomes of the condition, namely pain intensity, it is still unclear what 
underlying processes are involved in the psychological factors mentioned above. 
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Effects of Chronic Pain and Illness on Identity 
Ample research has demonstrated that individuals with chronic pain experience a 
change in self-concept (Harris, Morley, & Barton, 2003; Hellstrom, 2001; Leventhal, 
Idler, & Leventhal, 1999) after the onset of chronic pain.  This may manifest as feeling as 
though they are someone different than they were prior to pain or that they have “lost” 
defining characteristics of their life and self.  According to Leventhal (1999), chronic 
illness can often interfere with executing formerly manageable activities, creating an 
emphasis on what individuals cannot do.  This emphasis on inabilities may in turn lead to 
changes in self-concept.  These changes in self-concept or self-schema have been noted 
in patients with chronic low back pain, arthritis (Harris et al., 2003; Miles, Curran, 
Pearce, & Allan, 2005), chronic fatigue syndrome (Dickson, Knudsen, & Flowers, 2008), 
systemic lupus erythmatosus (Denton, Sharpe, & Schrieber, 2004), and most recently 
FMS (Steiner, 2009). 
A common theme in the literature is the loss or death of the “past self”.  
Qualitative studies have provided compelling evidence that patients feel a loss of self as a 
result of living with a chronic illness (Corbin, 2003; Dickson, et al., 2008).  One study 
found that individuals with chronic fatigue distinguished between their life prior to the 
onset of their illness and their current life (Dickson et al., 2008).  The responses of 
individuals in this study were demonstrative of two different lives, or two different ideas 
about themselves.  Several of the participants reported a sense that part of them was 
missing and they no longer felt they were truly themselves (Dickson et al., 2008).  Smith 
and Osborne (2007) found similar self-reports in people with chronic low back pain; in 
their study, individuals’ responses included comment such as “I can’t be me” and “It’s  
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the pain, it’s me”, possibly indicating an integration of self and pain.  Similarly, 
Hellstrom (2001) found that chronic pain patients felt as though they were trapped by the 
present; they were neither able to recall their lives before the onset of pain nor were they 
capable of imagining a future unaffected by pain.   
A possible self is an idea of what one could become based on representations of 
the self in both the past and future (Markus & Nurius, 1986).  The inability to imagine a 
satisfying future self is known as a negative possible self.  Negative possible selves are 
representative of a feared version of the self.  People with chronic pain or illness may 
imagine their future self as confined to a wheelchair instead of being able bodied.  
Consequently, this construct of the possible self can become incorporated into the present 
self (Markus & Nurius, 1986).  This may contribute to psychological distress which may 
lead to further changes in an individual’s self-concept (Marcus & Nurius, 1986).  A 
similar change in self-concept is related an inability to live up to the ideal self.  This is 
the version of the self the individual desires to become (Compan et al., 2011) and  the 
inability to live up to this ideal may be partially related to all of the possibilities that are 
no longer deemed attainable after the onset of pain.  
Because of the nature of FMS, one might expect that changes in self-concept 
would be common; however few studies have specifically aimed to understand the self in 
a sample of FMS patients.  A recent study by Compan et al. (2011) compared 30 women 
with FMS to a group of women without that diagnosis, through a structured interview.  
Women with FMS were found to have a greater amount of discrepancy between their self 
and their ideal self than women in the control group.  This research is consistent with 
other qualitative work with chronic pain patients.  
 5 
In addition to changes in self-concept that are common in people with chronic 
pain and illness, some individuals start to attend to pain-related information to a greater 
extent than people who do not experience chronic pain (Haggman, Sharpe, Nicholas, & 
Refshauge, 2010; Liossi, Schoth, Bradley, & Mogg, 2008; Liossi, White & Schoth, 2011; 
Khatibi et al., 2009; Schoth & Liossi, 2010).  This bias toward pain-related information 
can be thought of  as a pain “filter” or “lens” through which all other information must 
pass ; this may be similar to the “mental filter” that is often described in cognitive therapy 
(Burns in Caudill, 2009).  It is a tendency to see the world and one’s self as being 
integrated with the pain or symptoms of their illness.  A great deal of quantitative data 
has been collected on this pain bias. I recently evaluated 31 individual studies of pain-
related biases in chronic pain (Steiner, 2011) and found that 80.8% (21/26 studies) 
supported the notion that chronic pain patients exhibit a bias toward pain-related 
information when compared to healthy controls.  Attention to pain on a regular basis may 
serve to reinforce the idea that pain is an integral part of one’s life or identity.  
Interestingly, although this bias has been well supported in the literature there have yet to 
be any interventions designed to target the pain bias or changes in identity, which is the 
primary aim of the study proposed here. 
 
 
The Schema-Enmeshment Model of Pain 
 
In 2001, the schema-enmeshment model of pain (SEMP; Pincus & Morley, 2001) 
was developed to serve as a framework for better understanding changes in self resulting 
from chronic pain.  Self-schemas are “cognitive generalizations about the self, derived 
from past experience that organize and guide the processing of self-related information”  
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(Markus, 1977, pp 64).  They are representations of how one perceives one’s self, and 
these schemas are at the core of how a person defines the self and personal identity.  The 
self-schema helps individuals to process and organize new information as either 
consistent or inconsistent with their concept of “self” (Markus, 1977).  Although self-
schemas are somewhat resistant to new information that is not viewed as “self like”, 
major life changes such as the onset of chronic pain can modify the self-schema.  Self-
schemas are strongly influenced by one’s perception of self (Markus, 1977) which may 
happen through processes described in self-perception theory (Bem, 1972).  According to 
self-perception theory, we often observe our own behavior in order to make inferences 
about ourselves (Bem, 1972).  In the case of chronic pain or FMS, an individual might 
observe that they are no longer able to participate in high impact activities and over time 
come to the conclusion that they are someone who is limited or defined by pain.   
Research has provided support for the idea that some individuals with chronic 
pain conditions experience a change in self-schema or self-concept (Dickson et al., 2008; 
Morley et al., 2005).  In these cases, the person’s self-schema may change from one in 
which they were a well-adjusted healthy person to a self-schema of a person whose entire 
life is influenced by the pain.  People may no longer be able to separate their ideas about 
pain (pain schema) and self (self-schema) into distinct entities.  Instead, for some people 
the pain and self-schema may become one and the same, such that the person associates 
pain as an integral part of his or her identity.  Schema-enmeshment is a term that has been 
used to describe this integration (Pincus & Morley, 2001), and is the focus of the study 
proposed here.  According to Pincus and Morley (2001) there are three components or 
schemas in the Schema-Enmeshment Model of Pain (SEMP; see Figure 1): self, pain, and  
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illness.  If these three schemas significantly overlap and become enmeshed, distress and 
psychological problems such as depression may result, further exacerbating the chronic 
pain condition (see Figure 1). 
 The SEMP was originally developed based on the findings from research on pain-
related information processing biases; however after carefully examining the research on 
IPBs, I suggested revisions to the SEMP (Steiner prelims, 2011).  One of the most 
significant findings to come out of my recent review was that there are differences 
between sensory-pain information biases and affective-pain information biases.  These 
findings are consistent with the notion that pain is not a unidimensional concept.  Pain 
has been defined as “an unpleasant, sensory and emotional experience associated with 
actual or potential tissue damage or described in terms of such tissue damage” (IASP, 
1979).  By definition, pain has at least two distinct dimensions, sensation and affect.  The 
physical sensations of pain such as aching, burning, or throbbing may carry a different 
meaning than the affective experience of pain, which may be associated with feelings of 
hopelessness, frustration, or misery (Steiner, 2011).  Moreover, biases toward these 
dimensions are not equal.  The literature revealed that there was substantial support for a 
bias toward sensory-pain related information among people with chronic pain; however 
bias toward affective pain information was present only when individuals had co-morbid 
depressive symptomology (Steiner, 2011).  Differences often emerged between depressed 
pain patients and non-depressed pain patients, with only the depressed pain group 
displaying a bias toward affective information (Pincus, Pearce, McClelland, & Isenberg, 
1995).  It appears that the relationship between depression and enmeshment with pain or 
illness is a critical construct that needs further attention, as depression could potentially  
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exacerbate pain and both depression and enmeshment may impact quality of life.  Pincus 
and Morley (2001) suggested that biases (such as those mentioned above) led to the 
presence of schema-enmeshment with pain information, and this in turn results in 
psychological distress.  Thus, it is important to study schema-enmeshment as this 
experience is likely related to psychological health and quality of life, which may already 
be somewhat impaired in women with FMS because of physical limitations. 
 
 
Measuring the Impact of Illness on Self 
 
 One of the greatest challenges in this field is determining how to effectively 
measure the impact of illness on the self.  The notion of “self” is by nature an abstract 
concept, and objective measurement of a subjective experience on an already indefinite 
construct is a difficult task.  This may partially explain the attention to pain-related IPBs 
in the literature.  Objective measures of recall and processing speed (such as the dot 
probe task or the Stroop) as a method of detecting bias toward pain words could provide 
one way of assessing the extent to which chronic pain has become associated with the 
self in one’s cognitive network.  Objective measures that assess cognitive biases related 
to pain are based on the principle that the brain organizes information into categories or 
schemas that allow us to process information efficiently (Markus, 1977).  A commonly 
referred to theory and explanation of the way the brain processes incoming information is 
the spreading activation theory (Anderson, 1976; Ratcliff & McKoon, 1981).  According 
to this conceptualization, information is organized into networks which are comprised of 
nodes or schemas.  The greater the association between two nodes the less time it should 
take for the information to “travel” from one to the other.  Although cognitive processing  
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is more complex than this simplified theory, it serves to illustrate the fact that cognitive 
processing tends to be faster for related information (Fazio, Sabonmatsu, Powell, & 
Kardes, 1986).  It is thought that this is especially relevant for information about the self 
(Markus, 1977); the more information is deemed to be associated with one’s definition of 
self the more likely it is to be processed faster (Calfas, Ingram, & Kaplan, 1997; Markus, 
1977) and stored in memory.  It is because of these principles that measures of processing 
speed and recall have been assumed to be capable of assessing the magnitude of the 
relationship between self and pain. 
 Indeed a great amount of quantitative work on the relationship between self and 
pain has been conducted using these types of measures.  Pincus and colleagues (1993) 
assessed the recall of pain-related words with chronic pain patients when the words were 
endorsed as either self-referential or in reference to another person.  Chronic pain patients 
were found to recall a greater number of pain words when they were in reference to self 
than in reference to another person; the comparison group of people without pain 
displayed no significant differences in recall based on the subject of reference (Pincus et 
al., 1993).  This is an example of how the self plays a role in determining the processing 
of information.  Other studies evaluated differences between chronic pain patients and 
controls on recall of pain-related words (without explicit reference to self or other) and 
individuals with chronic pain recalled more pain words compared to individuals without 
pain (Pincus, Fraser, & Pearce, 1998; Pincus et al., 1995).  It is assumed that because pain 
is relevant to people with chronic pain, they had greater recall.   
 In a similar manner, some assume that measures of processing speed such as the 
emotional Stroop task and Dot-probe assess a difficulty disengaging from pain related  
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information.  For example, in the emotional Stroop task individuals are presented with 
words (that fit into categories of pain, neutral, etc.) that are various colors and the 
individual must state the name of the color rather than reading the word.  Individuals 
should take longer to name colors when presented with words that are considered 
threatening, in this case pain words (Crombez, Hermans, & Andriaensen, 2000).  The 
basic premise is that the more pain is viewed as threatening to the self, the longer the 
subject will look at the word (because that information is relevant to their self and life) 
and the longer it will take to disconnect from the word in order to name the color.  The 
dot-probe task assesses selective attention (the amount of time required for participants to 
change focus after being presented information that is salient to them, i.e. a pain-related 
stimulus) by measuring response times.  Individuals are presented with a “fixation point” 
in the center of a screen, followed by two words (one above and one below the point).  
One word is a pain word and the other is another type of word.  One of the words is then 
replaced by a letter in the same location on the screen as that word.  Participants are 
prompted to press that letter on the keyboard as quickly as possible. The basic premise is 
that people with chronic pain will have faster responses when the letter is in the same 
location as the pain word because they will have been attending to that location to a 
greater extent because of the relevance of the word. Therefore, it should take longer to 
respond when the letter is presented in a different location from the pain word because 
the subject will have to disengage their attention from that spot (Dehghani, Sharpe, & 
Nicholas, 2003).  The duration of time that is needed to press the key is representative of 
the time required to disengage from the stimulus that is meaningful to the individual.  
There are two different types of trials on the dot-probe task: congruent and incongruent.  
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When the replacement letter appears in the same location as the pain word, this is said to 
be a congruent trial.  When the replacement letter appears in the same location as the 
comparison word, it is an incongruent trial. On congruent trials, faster response times 
indicate a bias toward the pain-related stimuli; on incongruent trials slower response 
times indicate bias as they represent a difficulty disengaging from the other (pain-related) 
stimulus. 
 In the past decade a fair amount of work has been conducted using these two 
tools.  There is ample evidence that individuals with chronic pain exhibit bias toward 
pain-related stimuli when assessed by either of these.  In my recent review of the 
literature, 37.5% of studies that used the Stroop and 81.8% of studies with the dot-probe 
found significant biases compared to controls when processing pain-related information 
(Steiner, 2011).  It is tempting to interpret the evidence for difficulty disengaging from 
pain-related information as a sign of schema-enmeshment as it seems to represent 
selective attention to information that is consistent with either oneself or a major aspect 
of one’s life.  However, it does not necessarily imply that an individual with a great 
amount of bias toward pain-related information is in fact experiencing an enmeshment of 
their pain-schema and self-schema.  It is possible that these individuals attend to this 
information and recognize pain as part of their self and their life, but they may not feel 
that it defines who they are or their course in life.  Thus, bias as determined by these tools 
may serve as an indicator of possible enmeshment (or risk for enmeshment), but they are 
assessing a distinctly different (albeit related) construct. 
 A different tool for measuring enmeshment is the Pictorial Representation of 
Illness and Self Measure (PRISM; Buchi, Villiger, Kauer, Klaghofer, Sensky, & Stoll,  
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2000).  This is an interactive task which provides a visual representation of how 
individuals view themselves in relation to their illness/pain.  The task includes the use of 
two disks, labeled “self” and “illness”.  Participants are asked to arrange the disks as they 
conceptualize their own experience with illness (see Figure 2).  The distance between the 
centers of the disks is the level of Self Illness Separation (SIS).  Smaller distances are 
associated with greater enmeshment (Buchi et al., 2002; Denton et al., 2004).  In this way 
respondents are able to depict the magnitude of the impact of their illness on their 
identity. 
The PRISM was used as a measure of schema-enmeshment in a sample of women 
with Systemic Lupus Erythmatosus (SLE) a chronic autoimmune disease associated with 
pain (Denton et al., 2004).  In this study, SIS was correlated with recall bias toward pain-
related words. As stated previously, recall of information is thought to be stronger when 
information is associated with one’s self in some meaningful way, and the PRISM 
explicitly addresses variables in relation to the self.  The correlation between the PRISM 
and bias may imply that both measures are tapping into a similar yet still distinct 
construct that centers around the association between self and pain.  Furthermore, the 
authors of this work suggested that the PRISM is a viable option for assessing schema-
enmeshment because of its relationship with cognitive bias measures such as recall, 
which played an important role in the development of the original SEMP model (Denton 
et al., 2004). 
 Other studies have used the PRISM to assess the impact of illness or suffering 
because of illness in various populations, which was the original goal for the instrument 
by its developers (Buchi et al., 2000). A recent study evaluated the utility of the PRISM  
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to assess burden of pain experienced by individuals with chronic pain (Kassardjian, 
Gardner-Nix, Dupak, Barbati, & Lam-McCollock, 2008).  Several measures were 
compared to the PRISM to assess convergent validity of the scale and correlations with a 
well-validated measure of quality of life (the SF-36), such that pain disks placed further 
away from the self (high SIS) were associated with higher scores on the SF-36 and 
greater quality of life (Kassardjian et al., 2008). Correlations in this study ranged from r = 
0.24-0.46.  Similar correlations have been found with other samples of chronic pain and 
illness (Buchi et al., 2000; Buchi et al., 2002; Muhleisen, Buchi, Schmidhauser, 
Jenewein, French, & Hofbauer, 2009).  Content validity has been evaluated as well, and 
when respondents were queried, the extent to which pain was an important part of their 
image was a consistent theme in determining placement of the pain disk (Kassadjian et 
al., 2008).  Based on this work, there is support for the PRISM as a measure that in part 
addresses impact of illness on quality of life and the relationship of this impact to self.  
Importantly, the research on the PRISM suggests that it does assess a unique construct, 
the experience of self-enmeshment.  The correlations with other constructs that are 
assumed to play a role in the development and maintenance of schema-enmeshment are 
encouraging and provided a basis for the validity of the measure.  It is expected that 
constructs that are related would have some level of association with each other; however 
if the PRISM were just another measure of suffering or burden then correlations would be 
much higher.  Thus it can be said that the PRISM is measuring a construct that is closely 
related to suffering, burden of illness and quality of life but is also distinct; e.g. schema-
enmeshment. 
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Advantages of Using the PRISM 
 There is a fair amount of evidence to support the psychometric properties of the 
PRISM, especially in regard to construct and content validity.  However, if the PRISM is 
assessing similar constructs as pre-existing measures of cognitive bias toward pain 
information, then why not use said measures?  What does the PRISM offer?  First, the 
PRISM offers a unique way to directly assess the extent to which pain (or illness or 
another symptom) is a defining feature of one’s self.  Cognitive bias measures may 
demonstrate how closely these constructs are linked in the brain, but they do not 
necessarily measure the emotional impact of this cognitive relationship; nor do these 
measures demonstrate that presence of biases (or cognitive relationships between self and 
pain) indicate that pain is a defining feature of one’s self.  At best, measures of cognitive 
processing may be a sign that schema-enmeshment is present, but they do not assess 
enmeshment directly.  Likewise, self-report measures of quality of life may provide some 
indication of the impact of illness but often the focus is on functional impact rather than 
feelings about oneself.  The PRISM possesses several procedural advantages to measures 
of cognitive bias and self-report measures.  Although cognitive bias measures are useful 
in research, these measures are time-consuming and expensive, characteristics which 
makes them challenging to use in clinical practice (Steiner, 2011).  Self-report measures, 
although less expensive, can still take time to complete and score.  The PRISM can be 
completed usually in less than 3 minutes (Buchi et al., 2000) and is well understood by 
respondents (Buchi et al., 2002; Denton et al., 2004; Kassardjian et al., 2008; Steiner, 
2009).  Also important, the PRISM may be especially appropriate in clinical settings and  
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intervention research since the measure facilitates discussion between the individual and 
the therapist about the consequences of the illness.   
Additionally, the PRISM has demonstrated good test-retest reliability over a 24 
hour period of time with a sample of chronic pain patients, r = .980, p < 0.001 
(Kassardjian et al., 2008).  A high level of test-retest reliability such as this makes the 
PRISM a good candidate for use in intervention research as this meets the necessary 
requirement to potentially be sensitive to change over time.  The same is true for use of 
the PRISM in clinical settings as a measure of improvement or change during therapy. 
Research with other chronic medical conditions has found that the PRISM is sensitive to 
change (Muhleisen et al., 2009; Wouters et al., 2008).  Wouters and colleagues found 
significant changes in the PRISM following a multidisciplinary intervention for whiplash 
and attributed changes in schema-enmeshment to the intervention.  Similarly, Muhleisen 
et al. (2009) found the PRISM to detect large changes in dermatology patients during of 
an extended hospitalization period.  Although this is not the same as traditional 
intervention period, it does demonstrate that self schema-enmeshment with illness can 
change over the course of time and that PRISM is capable of detecting these  
differences.  It is for these reasons that the PRISM should be considered an acceptable 
measure for use with people who have chronic pain or illness, and was used in the present 
study. 
 
 
Previous Research on Enmeshment in FMS 
 
 To my knowledge, I have conducted the only study to examine the degree of 
enmeshment between self and pain and between self and illness in a sample of women  
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with FMS (Steiner, 2009).  In this study the association between self and aspects of FMS 
(pain and illness) was assessed using both the Implicit Association Test (IAT) and the 
PRISM.  The IAT is a computer task that is used to determine the association between 
two constructs without measuring them in an explicit manner.  The test is designed to 
circumvent issues associated with self-report (such as social desirability) by assessing 
implicit attitudes about the constructs.  At the time this study was conducted, only one 
other study had used this test to assess the relationship between self and pain in a sample 
of chronic pain patients (Grumm, Erbe, von Collani, & Nestler, 2008).  Interestingly, the 
IAT demonstrated greater association between self and illness compared to the 
association between self and pain (Steiner, 2009).  This was not consistent with the 
original hypotheses, possibly indicating that the participants in this sample were more 
enmeshed with the concept of having a chronic illness (e.g. FMS) rather than pain.  An 
alternative explanation for these findings is that for some of the women in this sample, 
pain was not the most salient aspect of their experience with FMS and so they responded 
to illness words as a proxy for the specific symptoms that were salient to them (or the 
symptom that they were enmeshed with).  This is a possible explanation as the stimulus 
words used to depict health on the IAT would be difficult to associate with oneself in the 
presence of any symptoms of illness; thus creating a stronger association between self 
and illness. For example, perhaps fatigue was the symptom that was most salient to the 
individual.  The Pain IAT did not include any stimulus words that would correspond with 
the symptom of fatigue; however, on the Illness IAT words such as energy were used to 
describe “health,” thus a woman with fatigue would not associate herself with the 
“health” category.  Thus it is possible that women with various symptoms other than pain  
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earned scores on the IAT that were indicative of a closer relationship between self and 
illness because of the lack of stimuli to assess their specific personal symptoms.  For this 
reason, it is important that the association between self and other symptoms associated 
with FMS be explored, as was done in the study presented here. 
The previous study detected a subgroup of participants with a high degree of 
enmeshment of pain and self, when assessed by the PRISM (Steiner, 2009); 23.5% of the 
sample put the pain disk on top of the self-disk, thereby showing complete enmeshment.  
A moderate significant correlation between the PRISM and the Constructed Meaning in 
Illness Scale (Fife, 1995) was found in this work and moderate correlations (r = 0.38-
0.56) were observed between individual items referring to impact of pain on self and the 
PRISM (Steiner, 2009).  The results of this study are consistent with previous finding 
regarding the construct validity of the PRISM as a measure of schema-enmeshment and 
support its use with individuals with FMS.  Based on the findings, I concluded that 
enmeshment or an association between self and illness was present to varying degrees in 
women with FMS.  This initial study provided support for the feasibility of using the 
PRISM to assess schema-enmeshment in women with FMS.  This study only examined 
schema-enmeshment with pain and illness.  An interesting finding was that there was a 
greater association between self and illness compared to self and pain when assessed by 
the IAT.  This finding prompted an interest in examining schema-enmeshment with FMS 
as a whole construct as well as enmeshment with the individual symptoms of the 
condition.  The current study aimed to address this question using the PRISM.   
To date only one other published study has used the PRISM with people who 
have FMS.  In this validation study, the FMS group was a subset of a larger sample, and  
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no analyses were conducted with regard to the FMS group in isolation (Kassardjian et al., 
2008); however there were no indications that this group responded differently than the 
other sub-groups of the sample.  Because enmeshment reflects a change in self-concept 
and is thought to be associated with psychological distress, interventions that aim to 
reduce the connection between self and the source of suffering should be explored. 
 
 
Acceptance-Based Interventions for Pain and Illness 
 
Acceptance of chronic pain and illness has been a growing area of interest over 
the past 15 years.  Acceptance has been defined as “acknowledging that one has pain, 
giving up unproductive attempts to control pain, acting as if pain does not necessarily 
imply disability, and being able to commit one’s efforts toward living a satisfying life” 
(McCracken, 1998, p. 22).  Acceptance does not mean that one gives in to the pain and 
simply decides to live a less than ideal life; acceptance implies that one is able to move 
on with life and live with the chronic pain or illness while still being aware that the 
condition may not dissipate.  The purpose is to live in a more goal-directed manner in an 
effort to improve one’s overall quality of life.  Greater acceptance of pain has been 
related to less depression, less anxiety, and less physical and psychosocial disability 
(McCracken, 1998).  Additionally, acceptance of pain has been shown to be a unique 
predictor of mental well-being in individuals with chronic pain. Acceptance has a 
significant positive effect on mental well-being even when controlling for the effects of 
pain, catastrophizing and pain severity (Viane et al., 2003). Through acceptance it is 
believed that individuals come to think differently about their relationship with their pain, 
i.e. their self-enmeshment with pain.
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Acceptance and Commitment Therapy 
 Acceptance and Commitment Therapy (ACT; Hayes, Strosahl, & Wilson, 1999) 
is considered to be part of a new generation of therapeutic interventions often called the 
“third wave”.  The interventions in this third wave share many of the same components as 
more traditional cognitive-behavioral approaches; however in theory these interventions 
place emphasis on changing people’s relationship to their thoughts rather than the actual 
content of the thought (Segal, Teasdale, & Williams, 2004).  For individuals who face 
situations that are relatively chronic and stable, traditional CBT methods such as 
gathering evidence against the validity of thought may not be beneficial.  For example, 
people who have lived with chronic pain for years may think pain is permanent.  People 
in this situation may think they are no longer who they were prior to pain.  Examining 
evidence against these thoughts may prove difficult as there is a great deal of truth to 
them. Additionally, even if an alternative thought can be created it may be that the person 
does not really believe in the new thought.  Continued pain experiences will serve to 
reinforce the original negative thoughts about pain and their self in relation to pain.  This 
reinforcement may occur in part through self-observation of these experiences which then 
become incorporated into one’s self-schema.  ACT may provide another way to address 
this issue.  Instead of attempting to dispute the validity of the thought, ACT emphasizes 
working to change how one is connected to the thought and how to move forward.   
 
 
The ACT Framework 
 
 ACT is grounded in two theories: functional contextualism (Bigland & Hayes, 
1996; Hayes, 1993; Hayes & Brownstein, 1986) and relational frame theory (RFT;  
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Hayes, Barnes-Holmes, & Roche, 2001).  According to the view of functional 
contextualism, psychological processes and events, such as thoughts, are integral parts of 
the whole organism; these processes do not occur in isolation and they interact with the 
context that they take place within (Hayes, Luoma, Bond, Masuda, & Lillis, 2006).  
Instead of just changing the thought, the entire context and environment that created and 
enforced the thought could be changed.  RFT suggests that language and cognition are at 
the root of how people form relations and connections between constructs in the mind 
(Hayes et al., 2006).  According to Hayes and colleagues (2006), the way that language 
interacts with context is the cause of distress and/or psychopathology.  In individuals with 
chronic pain, who may have developed a belief that they are no longer a useful person, 
this is not just a thought that can be altered, this is a part of who they are and how they 
exist in the context of being a person with chronic pain.  The ACT and RFT framework 
would suggest that through context and experience “I” and “chronic pain patient” have 
become fused in the mind and this in turn contributes to behaviors that are consistent with 
that relationship. 
 The ACT model has six core components that are key to understanding people’s 
relationship with their thoughts.  Cognitive fusion is a critical component in this model.  
Hayes et al. (1999) defines cognitive fusion as “excessive or improper regulation of 
behavior by verbal processes, such as rules as derived networks”.  Behavior is guided by 
the inflexibility of the network and by reinforcers in the environment.  Individuals start to 
behave in a way that is congruent with their thoughts about themselves, which 
perpetuates the cycle. The thought or relationship between ideas becomes truth.  This is 
actually very similar to the way we understand enmeshment; schema-enmeshment occurs  
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when the problem (in this case chronic pain and illness) and the associated behavioral 
changes start to define the person.  As the person continues to engage in behaviors that 
are schema-consistent, this will further reinforce the belief that they are their illness.  For 
example, an FMS sufferer may start to experience symptoms and as a result may start to 
limit her physical activity, or a member of her family may encourage her to do so in order 
to prevent further pain.  As she continues to avoid physical activities or obligations, she 
could potentially start to view herself as a “fibro patient” rather than a person with FMS.  
Once this labeling has occurred, every time she confronts a situation that may be 
challenging she may have the thought “I cannot do that because I’m a fibro patient.”  The 
language/label/thought guides her future experiences and leads to a strong association 
between her personal identity and her illness. The ACT perspective would identify this 
experience as cognitive fusion. 
Another integral part of ACT is an emphasis on contact with the present moment.  
Clients are encouraged to focus on the present rather than dwelling on past selves or lost 
possible future selves, which could in turn reinforce the relationship between their current 
self and pain (Hayes et al., 2006).  A third component is known as self as context.  This 
idea refers to the fact that self serves as a foundation for which relationships in the mind 
are formed, and so most information is attached to our definition of self in some way.  In 
ACT, clients are taught to have experiences without forming inflexible attachments to 
their sense of self.  For example, a person could experience a particularly painful day but 
that does not mean that they are their pain.  Acceptance is another key process; this 
process involves becoming capable of acknowledging events that are part of one’s 
personal history (such as having chronic pain) without attempting to change the event,  
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especially when doing so may be futile and lead to distress (Hayes et al., 2006).  This is 
especially relevant for individuals with pain or chronic illness as attempts to control the 
physical symptoms could be never-ending, thus becoming a major component of one’s 
life and identity. 
The other two components of ACT are considered ways to foster acceptance and 
cognitive defusion. Defusion is an ACT-specific word that refers to the process of 
separating the emotional connection to a thought and the thought itself.  In pain-specific 
ACT, defusion would involve creating cognitive distance from deeply held beliefs about 
self and pain.  For example, if a person believes that “I am my fibromyalgia”, the 
separation of the individual from the actual experience of FMS is what is known as 
defusion.  In many ways, this could be thought of as an opponent process to schema-
enmeshment. Values and committed action refer to encouraging the client to work toward 
their personal goals and live a life that is aligned with their values rather than living 
focused on what is preventing them from reaching said values.  According to the model, 
all six processes are inter-related and serve to reinforce one another; through these 
components psychological flexibility may be achieved (see Hexaflex; Figure 3) which 
may help a person to become less entrenched in their pain. 
 
 
Relationship to the SEMP 
 
 Many of the components of ACT map onto the ideas associated with the SEMP.  
Cognitive fusion seems to be closely related in theory to schema-enmeshment.  The 
common theme is that individuals have a sense of self that serves as a starting point from 
which relationships with other concepts are formed.  In both cognitive fusion and  
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schema-enmeshment, the self becomes associated with a thought or construct which is 
not useful and becomes the framework for thoughts about the self and the world.  These 
constructs appear to be remarkably similar, possibly even referring to the same process 
by different names.  If ACT is capable of breaking this fusion, then perhaps it is a viable 
candidate for treating pain and self schema-enmeshment.   
Additionally, the ACT intention to focus on present may be an especially 
appropriate approach for individuals who are enmeshed with their illness or its 
symptoms.  This enmeshment signals a preoccupation with mourning for lost selves (past 
or future).  Individuals who have adopted a self that is enmeshed with pain are limiting 
themselves on a daily basis on what they can or cannot achieve.  Rather, ACT encourages 
a focus on the present as a “jumping off point” to building a life that is more consistent 
with one’s desires, goals, and values.  ACT strongly emphasizes the importance of 
behavior, specifically ACTion, and how actions should move one in the direction of what 
is important to them rather than being guided by pain or maladaptive thinking (Hayes, 
Strosahl, & Wilson, 2012).  This may help individuals begin to see themselves differently 
as they move away from the control of the illness or a life that is completely dominated 
by pain and illness.   
 
 
Empirical Support for Acceptance-Based Interventions 
Several studies have been conducted with various medical populations to test the 
efficacy of Acceptance-based interventions (ABI) for chronic pain and illness.  
McCracken and Eccelston (2005) measured acceptance and several facets of patient 
functioning at baseline and again approximately 2-6 months later in 118 inpatient chronic  
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pain patients.  Greater levels of acceptance at baseline were predictive of better patient 
functioning in emotional, social, and physical domains at the later assessments. A fairly 
recent study (Vowels & McCracken, 2008) evaluated the effect of an intensive ABI on 
171 inpatient individuals with chronic pain.  The intervention consisted of methods from 
ACT and mindfulness based approaches.  Results of this work demonstrated statistically 
significant improvements in pain, depression, physical functioning, pain-related anxiety, 
work status, and frequency of medical visits (Vowels & McCracken, 2008).  Perhaps 
most importantly, large reductions in unemployment were seen in this sample with the 
percentage of individuals working increasing by approximately 10% from baseline to 3 
month follow-up.  This finding is especially relevant as it may indicate a willingness to 
continue living in pursuit of a more active life rather than succumbing to the physical 
pain.  Of note, there was no control group in this study, thus comparisons are across time 
within a single group. Similar results have been found for other samples of patients 
undergoing acceptance-based therapy for chronic pain by the same research team 
(McCracken, Vowles, & Eccelston, 2005, McCracken & Eccelston, 2005). 
In addition to single cohort studies, a few randomized controlled trials of ABI 
have been conducted and have yielded encouraging findings.  Dahl and colleagues (2004) 
conducted an RCT comparing ACT for chronic pain to treatment as usual, with the goal 
of reducing sick days taken from work and use of medical resources.  Specifically, the 
authors stated that the goal of the intervention was not to reduce physical symptoms or 
stress that could exacerbate symptoms, but to change the way that individuals relate to 
the stress and pain (Dahl et al., 2004).  After treatment, individuals in the ACT condition 
had significantly fewer sick days compared to the treatment as usual group (M = 1 day,  
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M = 11.5 days, respectively).  These differences were even greater at 6 month follow-up.  
The number of medical visits also decreased for the ACT group and these reductions 
were maintained at follow-up.  What is interesting about this particular study is that 
following the intervention period, there were no differences between groups in stress or 
pain, and stress and pain did not improve as a result of the intervention.  Similar results 
were found by Wicksell and colleagues (2008) such that the group that received 
acceptance-based therapy displayed significant improvements in depression, pain 
disability and life satisfaction.  These improvements were greater than those observed in 
the control group; however no changes in pain intensity were observed in either treatment 
condition.  This is especially meaningful as individuals in the ACT condition had marked 
reductions in sick days, medical utilization (Dahl et al., 2004), disability, and 
psychological distress (Wicksell et al., 2008) despite still experiencing similar levels of 
pain and stress.  Dahl et al., 2004 concluded that these results were due to a change in the 
way that individuals approached their illness, so that it was no longer controlling their 
lives. 
Despite the new interest in acceptance as an important predictor of overall 
functioning in pain patients, no studies to date have examined the role of acceptance in 
relation to schema-enmeshment.  Given the core tenets of ACT, it seems to be an 
especially appropriate type of intervention to target schema-enmeshment.  Furthermore, it 
is important to try to understand how acceptance may contribute to changes in schema-
enmeshment.  According to ACT principles, change is produced by fostering an attitude 
of acceptance (Hayes et al., 2012) and it is assumed that acceptance is one of the 
fundamental mechanisms of action in this type of psychotherapy, however the exact role  
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of acceptance in predicting change in any outcome (not just schema-enmeshment) has not 
been determined (Arch & Craske, 2010).  ACT specifically targets behavior, rather than 
changes in thoughts or emotions; however change in the way that one relates to thoughts 
and emotions is consistent with ACT ideals (Hayes et al., 2012).  Specifically, ACT 
includes exercises to encourage learning to relinquish maladaptive attempts to control 
pain and instead engage in meaningful life activities even in the presence of pain [pain 
acceptance], which according to theory should be related to a changes in the way that one 
relates to their thoughts about pain and their self (Hayes et al., 2012).  One way in which 
pain acceptance may be predictive of changes in thoughts about self lies in self-
perception theory (Bem, 1972).  The basic premise of this theory is that we observe our 
own behavior to infer how we feel about situations and ourselves (Bem, 1972; Wilson & 
Dunn, 2004).  The simplest example may be someone notices that they are always going 
out of their way to help others; they may conclude that they are a helpful person.  In the 
context of ACT for chronic pain, an individual may notice that they are able to work, 
spend time with their family, or do other activities that they find important and thus they 
may observe this behavior and think “I am a complete person even though I have pain”.  
It is possible that the acceptance, when it leads to engagement in core life values, works 
in this way to undermine schema-enmeshment of self with FMS.  Although pain 
acceptance is comprised of both a behavioral aspect (activity engagement) and a 
willingness to experience pain without control attempts (pain willingness), this suggests 
that the behavioral aspect is the specific component of acceptance that leads to changes in 
thoughts.  A pure focus on activity engagement as a potential mechanism of action or 
mediator of change would be consistent with self-perception theory (Bem, 1972) as  
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individuals look to their behavior to make inferences; this would also being in alignment 
with the idea of ACT as a behavior-focused therapy.  However, it is possible that pain 
willingness could still play a role as individuals may interpret their choosing to refrain 
from engagement in control behaviors as the action that is reflected upon.  Therefore, I 
examined both subscales separately as they are considered to be distinct but related 
aspects of pain acceptance, and the unique roles of activity engagement and pain 
willingness in relation to schema-enmeshment, or changes in self related thoughts are 
unknown.  
 
 
Research Questions and Hypotheses 
The present study tested an 8 week randomized controlled ACT intervention for 
patients with FMS.  I hypothesized that compared to an education control, ACT will lead 
to reductions in schema-enmeshment.  I also hypothesized that ACT will increase 
acceptance of pain since previous intervention studies have demonstrated this.  Lastly, I 
hypothesized that changes in acceptance of pain (specifically activity engagement) would 
lead to changes in schema-enmeshment of self with FMS symptoms, and that this would 
mediate a potential relationship between treatment group and changes in enmeshment 
post-intervention.  Specifically if individuals develop greater acceptance of their pain, 
they may be able to view pain as something that does not control them or dictate their self 
worth, and they will not let their self be determined by their symptoms. 
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Hypothesis 1 
Research Question 1: Does receiving ACT lead to reductions in enmeshment?  
Hypothesis 1: There will be a significant difference between the ACT group and 
education group in post-intervention enmeshment as measured by the PRISM, when 
controlling for baseline enmeshment.  If this difference is significant, means will reflect 
greater reductions in enmeshment for those in the ACT group.  
 
 
Hypothesis 2 
Research Question 2: Does receiving ACT lead to increases in acceptance?  
Hypothesis 2: There will be a significant difference between the ACT group and 
education group in post-intervention acceptance of pain as measured by the CPAQ, when 
controlling for baseline acceptance.  If this difference is significant, means will reflect 
greater increases in acceptance for those in the ACT group. 
 
 
Hypothesis 3 
Research Question 3: Does acceptance of pain mediate the relationship between group 
membership and changes in schema-enmeshment as self-perception theory may suggest?   
Hypothesis 3a: Activity engagement (acceptance of pain will mediate the relationship 
between group membership and change in schema-enmeshment (see Figure 4).  
Hypothesis 3b: Pain willingness (acceptance of pain) will mediate the relationship 
between group membership and change in schema-enmeshment. 
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METHOD 
 
 
 
Design 
 The present study used data collected from a larger-scale pilot RCT of 
Acceptance and Commitment Therapy for FMS.  In the RCT participants were randomly 
assigned to receive ACT or FMS/pain management education.  Randomization took place 
through a “coin-flip” method in order to assure true randomization in which each 
prospective participant had an equal chance of being assigned to each group. Although 
this method does not ensure equal sample size across treatment conditions, it is a more 
reliable way compared to blocking methods to establish an equal distribution of 
demographic and clinical characteristics; furthermore, this method is supported as a 
superior way to establish true randomness compared to blocking approaches (Schultz & 
Grimes, 2002).  Once randomized, participants completed approximately 8 one-on-one 
sessions with the interventionist or the educator.  Sessions occurred once a week for 1 
hour at a time.  Within the ACT arm of the study the number of sessions was flexible.  If 
both the participant and the interventionist determined that the goals of the intervention 
had been achieved by week 6, the last two planned meetings were cancelled.  If they 
determined that more sessions were needed past the 8 weeks, two additional sessions 
were scheduled.  No participant (except those who dropped out of the program) had less 
than 6 or more than 10 sessions.  The reason for making the duration of the intervention
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 period flexible was to make the intervention consistent with ACT principles.  This was 
not viewed as a threat to the standardization of the study as the goal was to assist each 
participant in reaching their full-potential that they can gain from the intervention 
(whether that potential is realized in 6 sessions or in 10).  Recently, there has been a 
movement toward adaptive treatment strategies for interventions with predetermined 
“choice points” for determining the next action in the intervention (Murphy, 2005).  
Furthermore, the number of sessions completed was controlled for in all relevant 
analyses.   
The manualized ACT intervention included the following components: (a) 
assessment, conceptualization, rationale, and rapport; (b) willingness to contact unwanted 
emotion; (c)  introduction to cognitive defusion; (d) introduction to values and value 
clarification; introduction to committed action; (e) willingness, mindfulness, present 
moment, and defusion; (f) further establishing values; (g)  committed action; (h) self as 
context and committed action. The ACT intervention was based on a manual entitled 
Living Beyond Your Pain: Using Acceptance and Commitment Therapy to Ease Chronic 
Pain (Dahl & Lundgren, 2006).  Although a suggested order of intervention components 
was provided, it should be noted that ACT is often less sequential than other 
interventions. This is because the various ACT components are simultaneously present 
more or less in all sessions and largely dependent on one another (e.g., patients are taught 
to accept their painful experiences, when and if controlling/avoiding these events are 
interfering with his/her values). As such, flexibility in presentation order and time spent 
on components was built into the protocol and to the discretion of the interventionist and 
the supervising clinician.  
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Despite the relative flexibility in the order of presented topics within the ACT 
protocol, the exercises within each topic were standardized.  Participants were taught that 
previous attempts to control, avoid, or manage pain were ultimately futile as pain is 
chronic in nature; this shift in thinking was fostered through a process known as creative 
hopelessness which is integral to ACT.  Participants were encouraged to explore their 
personal values (and the ways in which control strategies interfere with said values) 
through completing the Valued Living Questionnaire (Dahl & Ludgren, 2006, pg. 45).  
Participants were taught mindfulness techniques in order to practice experiencing 
thoughts, emotions, and physical sensation related to pain and FMS without becoming 
fixated on these experiences.  Mindfulness exercises such as being in the moment (Dahl 
& Lundgren, 2006, pg. 99) in which the individual practices experiencing pain and 
associated thoughts without judgment were included in each session.  Furthermore, 
participants in the ACT group were asked to practice mindfulness on a daily basis as 
homework.  Defusion techniques such as the arrogance of words, this is me thinking, and 
kicking your buts (Dahl & Lundgren, 2006, pg. 75, 78, and 80 respectively) were used to 
demonstrate separating one’s self from one’s thoughts.  Likewise, self-as-content 
exercises such the observer self and the chessboard metaphor (Dahl & Lundgren, 2006, 
pg. 89 and 91 respectively) were introduced to demonstrate that the individual is greater 
than their pain.  All of the aforementioned exercises are variations of classic ACT 
techniques; a detailed description of each is available in the manual as well as Hayes et 
al. (2012).  This intervention focused heavily on encouraging participants to commit to 
behaviors that would reflect their stated life values (committed action).  Participants were 
assigned a “committed action” as homework every week.  It is important to note that  
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 participants were instructed to complete these behaviors even in the presence of pain or 
discomfort.  Worksheets pertaining to each topic were also assigned as homework. 
The Fibromyalgia/Pain Management intervention consisted of education on the 
following topics: a) overview of FMS; b) pain; c) fatigue; d) mood; e) sleep; f) stress; g), 
nutrition; h) living well with FMS.  This manualized education control intervention was 
adapted from a manual (Oliver, Cronan, Walen, & Tomita, 2001) that has successfully 
been used in other RCTs with FMS patients (Ang et al., 2011).  Participants in the 
education intervention were provided with a written copy of the educational material at 
each session; the participant and interventionist discussed the material together.  
Information was provided in a conversational manner and the interventionist asked 
standardized questions to elicit the participants’ thoughts, feelings, and reactions related 
to the material.  Participants were encouraged to relate the material to their own 
experience and to share this with the interventionist.  Interventionists did not actively 
encourage participants to adjust their behavior based on the information provided.  
Participants in the education group did not receive homework assignments. 
Data from the initial screening, baseline, and post-intervention assessments was 
used to evaluate the hypotheses presented above.  The analyses for this study were 
prospective and longitudinal.  A detailed data analysis plan is outlined in subsequent 
sections. 
 
 
Recruitment 
 
Participants in this study were women diagnosed with FMS (N = 28).  
Recruitment took place through a variety of methods including flyers, doctor referrals,  
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 referrals from the IU Clinical Research Center for Fibromyalgia-Pain (IUCRCF-P), 
newspaper advertisements, and a general Rheumatology recruitment database.  Flyers 
were placed in doctor’s offices, pain clinics, and various public locations across the 
Indianapolis metropolitan area.  An advertisement on the IU research website was also 
posted.  Participants from previous studies conducted by the IUCRCF-P served as 
participants for the proposed study as well.  Potential participants from the recruitment 
database or physician/center referral were contacted via telephone call and asked to 
participate in the proposed study. Volunteers interested in the study after receiving a flyer 
contacted the study manager (myself) via telephone or email.   
During the initial contact, I briefly described the study purpose and the 
commitment required from the participant (see Appendix A).  If the individual was 
interested in participation, she was asked to complete a brief 10-15 minute questionnaire 
to determine eligibility for the study.  This could be completed on the telephone, or 
online through the secure data capture system (REDCAP).  I hand scored the 
questionnaire.  Once eligibility was determined, participants were contacted via their 
method of choice (telephone or email) and notified of their eligibility status.  Those 
individuals who were deemed eligible continued on to complete an online informed 
consent statement and participate in the rest of the study procedures. 
A large recruitment source was a database which consisted of women who had 
either participated in past studies or expressed general interest in participating in research 
studies.  This recruitment database was compiled by the IUCRCF-P.  In addition to 
recruitment through the database, other mediums such as flyers, physician referral, and 
referrals from the IUCRCF-P were utilized.  However it should be noted that these  
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 methods overlapped with the recruitment database and no additional potential 
participants were identified through these methods.  Phone calls were made from this 
database (and return calls were made to those who expressed interest on their own, 
resulting in contact with 77 women directly (of approximately 435 attempts). Of the 77 
with whom I had direct contact, 56 agreed to be assessed for eligibility to participate in 
the study.  Women who were spoken to directly on the phone, refused the study because 
of several reasons: 10 reported they were doing well and were not interested in any other 
treatment options at this time, 4 because of inability to commit to a study that included so 
many visits, 4 refused because of lack of time/too many other commitments, and 3 did 
not have travel accommodations.  From this group 37 women met criteria and of these, 4 
decided not to participate after screening, resulting in a total sample size of 33 women 
who provided consent to participate in the study (recruitment detail provided in Figure 5).   
Participants were randomized into one of two conditions; ACT or educational 
control.  Randomization appeared to be effective (ACT N = 18; Ed N = 15); however 
attrition over the course of the study resulted in uneven group sizes at post-intervention 
(ACT N = 15, Ed N = 9; see CONSORT chart Figure 5).  A total of 28 participants 
completed the baseline assessment and 24 completed the post-intervention assessment.  
Estimated power for an ANCOVA based on this sample size was 0.53 (G-power). Actual 
observed power ranged from 0.51- 0.78. 
 
 
Eligibility Criteria 
 
The following inclusion criteria had to be satisfied to participate in the study: 1) 
diagnosed with FMS by physician, 2) score at 40 or above on the Fibromyalgia Impact  
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 Questionnaire; this is a cut-off score that has been used in other trials with FMS patients 
(Ang et al., 2011) to guarantee that the FMS is impacting the ability of individuals to 
perform activities of daily living, 3) age between 18-65 years, 4) ability to attend 1-hour 
weekly sessions for 8 weeks and to engage in required home practice, 5)  willingness to 
be randomized into two different intervention groups, 6)  on stable doses of the following 
medications for at least 4 weeks: cyclobenzaprine, tramadol, gabapentin, pregabalin, 
tricyclics, selective serotonin reuptake inhibitor (SSRI) and selective norepinephrine 
serotonin reuptake inhibitor (SNRI), or a willingness to keep her medication regimen 
(whatever it is) stable for the duration or the study, and  7) able to read, speak and write 
in English.   
Exclusion criteria were as follows:1) active suicidal intention or plan, 2) other 
major rheumatic conditions, 3) schizophrenia or other psychosis (self-report and clinician 
assessment), 4) evidence of a possible Axis II disorder as assessed by the IOWA PD 
screener, and 5) dementia, neuropsychological problems, or cognitive impairment (self-
report and clinician assessment).  The decision to exclude individuals with possible Axis 
II disorders was made in an attempt to control for factors that may interfere with 
evaluating the efficacy of the intervention in the larger scale study, of which the proposed 
research is a component.   
 
 
Procedure 
 
 Once participants passed the eligibility screener they were randomly assigned to 
either the ACT or Education control group.  Participants were then contacted to schedule 
the intervention sessions.  They were not notified of their group assignment until after   
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online signature of the informed consent statement, completion of the first questionnaire, 
and scheduling of the first intervention session (with either the ACT therapist or the 
educator).  Participants were scheduled to attend 8 sessions of the intervention.  After 
successful completion of the intervention, participants completed a second questionnaire 
to assess the effects of the intervention (see Figure 6).  
 
 
Measures 
 
 
 
Demographics and Background Questionnaire  
 
The background information and demographics questionnaire included items 
regarding age, ethnicity, marital status, level of education, years since diagnosis, 
disability status, and any FMS related medications. 
 
 
IOWA Personality Disorder Screen 
 
The IOWA personality Disorder Screen is an 11item self-report measure.  The 
screen is intended to establish the presence of an Axis II disorder (personality disorder).  
Validation studies have shown that the screen is effective for diagnosing the presence of 
personality disorders, although the ability to distinguish between categories of personality 
disorders is lacking (Langbehn et al., 1999).  For the purposes of this study it was not 
necessary to identify a particular Axis II disorder, only the presence of a disorder so as to 
determine if the participant met inclusion criteria.
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Brief fatigue inventory (BFI) 
 
The BFI (Mendoza et al., 1999) is a self-report measure consisting of three items 
that require the participant to rate their level of fatigue on a scale from 0-10, with 0 = “no 
fatigue” and 10 =  “fatigue as bad as you can imagine.”  Participants then rate how their 
fatigue has impacted multiple life domains including general activity and enjoyment of 
life. These domains are rated based on interference due to fatigue on a scale from 0-10, 
with 0 = “does not interfere” and 10 = “completely interferes.”  (see Appendix B). 
 
 
Outcome Measures 
 
 
 
Pictorial Representation of Illness and Self Measure (PRISM) 
 
The PRISM is an interactive measure of self and illness/pain enmeshment that 
provides a visual representation of how individuals view themselves in relation to their 
illness/pain.  The task includes the use of two disks, labeled “self” and “illness”.  
Participants are asked to arrange the disks as they conceptualize their own experience 
with illness (see Figure 2; Appendix C).  The distance between the centers of the disks is 
the level of Self Illness Separation (SIS).  Smaller distances are associated with greater 
enmeshment (Buchi et al., 2002; Denton et al., 2004). As stated previously, the PRISM 
has demonstrated adequate convergent validity with other related measures of quality of 
life and impact of illness (Buchi et al., 2000; Buchi et al., 2002; Kassadjian et al., 2008; 
Muhleisen et al., 2009).  Content validity and adequate test-retest reliability of the 
measure is also well supported (Kassadjian et al., 2008).  In the present study the PRISM 
was used to assess self schema-enmeshment with FMS, pain, fatigue, and cognitive   
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symptoms such as trouble remembering things, difficulty concentrating, and feeling as if 
one was walking around in a haze.  Patients often refer to this experience as “fibrofog” 
and this term was used when administering the PRISM.   
 
 
Fibromyalgia Impact Questionnaire (FIQ) 
 
The FIQ is a self-report measure designed to assess the effect of FMS on various 
aspects of functioning, including the ability to execute certain tasks and ratings of pain 
levels (Burckhardt, Clark, & Bennett, 1991).  The measure consists of 10 tasks that 
participants must rate according to their ability to execute on a scale of 0-3, with 0 
representing “always” and 3 being “never”.  The measure also includes two visual 
analogue scales, and several items which ask the participant to mark a point along a 
continuum.  For example an item may read “How bad has your pain been?” In this case 
the participant would indicate the intensity of the pain by making a mark on a visual 
analogue scale ranging from  “no pain” to “very severe pain” (see Appendix D).  The 
measure is scored such that the first 10 items are averaged to create a physical 
impairment subscale which ranges from 0-3 with greater scores indicating greater 
impairment.  This subscale score is then added to the responses from the other items to 
create a total score ranging from 0-100; higher scores indicate greater impact of FMS (see 
Appendix D).  Additionally, one of the items on the FIQ is a visual analogue scale of pain 
severity over the past week.  The measure has demonstrated adequate discriminant 
validity when administered to individuals with other pain disorders, such that people with 
FMS have higher scores on the FIQ compared people with other conditions (Bennett, 
2005).  Additionally, a study by White and colleagues (1999) compared the FIQ with 8   
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other measures of distress and dysfunction and found that the FIQ better predicted self-
reported function than any of the other measures.  The FIQ has been used in over 100 
studies with FMS patients (Bennett, 2005) and is considered the gold-standard for 
assessing impact of FMS on patients. 
 
 
Mediator Measures 
 
 
 
Chronic Pain Acceptance Questionnaire (CPAQ) 
 
The Chronic Pain Acceptance Questionnaire (CPAQ) is a self report measure 
consisting of 20 items that assess an individual’s acceptance of their pain (McCracken, 
Vowles, & Eccelston, 2004).  Each item is rated on a 6-point scale according to how 
much the individual feels the statement applies to them (see Appendix E).  The scale 
ranges from 0-6 with 0 representing “never true” and 6 representing “always true”.  The 
scale is divided into two subscales, which are added together to create a total score.  One 
subscale assesses activity engagement or an ability to execute physical activities despite 
the pain and is scored such that higher scores indicate greater engagement.  It should be 
noted that the type of activity is not specified on the CPAQ, instead it is more generally 
assessed with items like “Keeping my pain level under control takes first priority 
whenever I’m doing something”.  The vagueness of these items is purposeful as 
acceptance-based interventions are focused on what activities are important to the 
individual; thus it may be exercise related activities or spending time with family. The 
second subscale focuses on pain willingness or the “recognition that avoidance and 
control are often unworkable methods of adapting to chronic pain” (McCracken et al.,  
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2004, pg. 161) and is scored such that higher scores indicate greater willingness to 
experience pain without the need to control or avoid the painful sensations.  The two 
subscales were derived through component factor analysis and have demonstrated good 
internal consistency (McCracken et al., 2004); furthermore the 2-scale structure was 
supported by confirmatory factor analysis in 2008 (Vowels, McCracken, McLeod, & 
Eccelston, 2008).  This scale has been used reliably in previous research on pain 
acceptance (Morley, Davies, & Barton, 2005). 
 
 
Measures to Assess Validity of the PRISM 
 
 
 
The Twenty Statements Test (TST)  
 
This is a self-report measure of self-concept that has been used in hundreds of 
studies of self-concept (Kuhn & McPartland, 1954).  This measure is displayed as a blank 
sheet of paper with the header: “There are twenty numbered blanks on the page below. 
Please write twenty answers to the simple question 'Who am I?' in the blanks. Just give 
twenty different answers to this question. Answer as if you were giving the answers to 
yourself, not to somebody else. Write the answers in the order that they occur to you” 
followed by twenty blank spaces (see Appendix F).  Themes in responses are then 
evaluated by the researcher and responses that occur first are considered more salient 
aspects of self-concept.  Test-retest reliability has been estimated as greater than r = 0.85, 
and the coefficient of reproducibility ranging from 0.89-0.90 (Kuhn & McPartland, 
1954).  The validity of the scale is difficult to assess because of the nature of the measure 
itself and the personal nature of the concept of self.  
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The TST was used in this study as a means of establishing convergent validity 
with the PRISM.  If the PRISM is indeed a measure of schema-enmeshment of self and 
illness then it should moderately correlate with other measures of self-concept.  This is 
important as the PRISM has been considered to be a measure of various self and illness 
related constructs including: burden of suffering and burden of illness to the self. 
Previous validation studies (Buchi et al., 2002; Kassardjian et al., 2008) of the PRISM 
have used verbal probing as a method of validating content and construct validity.  
Establishing a relationship between the TST and the PRISM would indicate that the 
PRISM is a measure that assesses an aspect of self and add to its construct validity.  See 
Table 1 for a complete timetable of measures and assessment periods.  
 
 
Data Collection 
 The majority of the data collection was completed through an online data 
collection system called REDCap.  REDCap is a software application originally 
developed by Vanderbilt University that is designed to collect and manage data from 
research projects and clinical trials electronically.  According to the developers:  
“REDCap and REDCap survey software are safe and secure web-based 
programs.  The servers hosting REDCap and REDCap Survey are 
physically located in a secured and environmentally structured computer 
operations center on the main campus of IUPUI and are supported by 
Division of Biostatistics server and database administrators.  To comply 
with HIPAA guidelines, processes and procedures have been documented 
and implemented to ensure the security and protection of the study and/or 
survey data within the computer operations center, the servers, and the 
databases.”  (Harris et al., 2009) 
 
A few questionnaires were mailed to participants and completed by hand in hard-copy (in 
the case that the participant lacked internet-access or was not familiar with the computer).  
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The PRISM was the only measure administered in person.  This was administered by the 
interventionist or a team member during the 1st and last session. 
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RESULTS 
 
 
 
The two aims of this study were to determine if there would be significant 
treatment group differences in schema-enmeshment of self with several FMS related 
symptoms, and with acceptance of pain following 8 weeks of either ACT or 
psychoeducation about FMS symptom self-management.  In addition, the potential role 
of activity engagement (a form of pain acceptance) as a mediator of the relationship 
between treatment group and changes in schema-enmeshment was assessed. The results 
of these analyses are presented in this section following a presentation of data cleaning 
and preparation and descriptive analyses.  
 
 
Data Cleaning and Preparation 
Prior to data analysis the dataset was carefully cleaned to ensure accuracy of the 
data.  Data was imported from the REDCap data capture system into SPSS version 19.  
The data was then inspected visually by myself and a research assistant to ensure 
accuracy of the data and detect any mistakes or inappropriate missing values.  Following 
this process, data cleaning procedures were followed. 
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Outliers 
   The dataset was inspected to make sure there are no values which were 
considered out-of-range for a given variable.  It is important to identify outliers as 
statistical tests which rely on means (such as ANCOVAs) are easily impacted by values 
that are far outside the group norms, as one extremely high or low value can pull the 
entire mean in the direction of that value creating a false estimate of the mean.  Outliers 
on all variables were identified within each group as is suggested when conducting 
analyses on grouped data (Tabachnik & Fidell, 1996).  First, univariate outliers were 
identified as those that have z-scores greater than 2.57 with a p-value less than 0.01.  The 
decision to use this cut-point was based on the recommendations of Tabachnik and Fidel 
(1996) as well as Cousineau and Chartier (2010).  Cousineau and Chartier (2010) suggest 
that when a sample is small and no Bonferroni correction is used, a z-score criterion 
should be 2.57 to detect an effect that is significant at the 0.01 p level.  Cousineau and 
Chartier (2010) also suggest that data be inspected for outliers visually, especially in the 
case of small sample sizes.  The reason for this is that in a small sample, outliers may be 
missed because of limitations in how large a z-score can be as a result of limited number 
of cases.  It is unlikely that a given value will ever be larger than the decision criterion 
which is directly related to the size of the sample, thus possible outliers would never be 
detected unless inspected visually.  Visual inspection of the data was performed to 
remove outliers.  Following both computerized and visual inspection of the data, three 
cases were removed because of outliers.  These cases were only removed from the 
analyses which utilized the variable on which the case was an outlier (rather than deleting 
the entire case).  The decision to handle outliers in this fashion was based on the small  
 45 
sample size; had the entire case been removed the sample size and statistical power 
would have been further reduced.   
 
 
Missing Data 
Although Tabachnik and Fidell (1996) suggest addressing missing data through 
imputation methods such as inserting the mean value of the group on that particular item, 
this is not supported by others (Cousineau & Chartier, 2010).  One of the advantages of 
using this method of imputation is that the mean distribution of the whole remains stable 
and does not require one to guess, making it the most conservative method (Tabachnik & 
Fidell, 1996).  Of course there are some drawbacks to this approach as well, such as 
reducing the spread of the distribution, possibly increasing risk of type I error (Cousineau 
& Chartier, 2010).  Missing data was minimal as the online questionnaire was set up so 
that the participant could not move onto the next page if an item had not been answered; 
however in accordance with IRB every item had “choose not to answer” as an option.  In 
this manner it was ensured that missing data is due to personal decision not to respond 
rather than simply missing an item in the large battery of questions.  Furthermore, intent-
to-treat analyses using the “last measure carried forward” method is an example of data 
imputation and additional imputation that would further increase risk of type 1 error. 
Only 4 cases were missing data on the PRISM measure, as a result of interventionist 
error.  Because missing data was minimal, and out of concern for type 1 error, further 
data imputation to address missing data was not used.  
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Normality 
It is also important to ensure normality (the extent to which the values of a given 
variable follow a normal distribution) as normality of data is a common assumption for 
most statistical tests.  This is especially relevant when sample sizes are smaller (as is the 
case in this study) as they are less likely to naturally conform to a normal distribution.  
Frequencies and graphic representations of the data were examined to help determine 
skewness and nonlinearity; these were followed up by the Kolmogorov-Smirnov and 
Shapiro-Wilks tests.  Levene’s tests of homogeneity of variance were also conducted to 
ensure that there was equal variance across groups.  
  At baseline, the CPAQ data was normally distributed so transformation was not 
necessary; however the PRISM data was not normally distributed.  All of the PRISM data 
was skewed to the right toward greater schema-enmeshment.  At post-intervention, the 
ACT data for PRISM FMS and PRISM fatigue were right skewed; the education group 
data for the activity engagement was bi-modal and PRISM fatigue were right skewed.  
All other variables were normally distributed.  Transformation of data is often 
recommended to ensure normality and equality of variance (Tabachnik & Fidell, 2001).  
In cases when transformations are performed, the analyses are typically conducted two 
ways (with and without the transformation) and the results are compared.  If the results 
are different, both sets of analyses are reported. This approach to the data was considered.  
However, statisticians have discrepant attitudes toward the use of transformations 
(Meyers, Gamst, Guarino, 2006).  One of the cautions of using transformations is that it 
can create challenges in interpreting the data as the transformed scores often look 
substantially different from the raw data (Meyes, Gamst, Guarino, 2006).  This may be  
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especially important when considering the way in which PRISM SIS is measured, such 
that 0 is a meaningful value indicating complete enmeshment.  Of note, there is a high 
frequency of 0 scores on all of the variables assessed with the PRISM.  Other researchers 
have recently suggested that transformation of independent variables is not appropriate 
when using “counts” since there are often a high number of 0 observations (Maindonald 
&Braun, 2007; O’Hara & Kotze, 2010). O’Hara and Kotze (2010) demonstrated that in 
general, transformations perform poorly when dealing with data in which there are a high 
number of 0 observations. Although the present study did not use counts per se, the high 
frequency of 0 scores on the PRISM measures could potentially cause inappropriate 
interpretations when data are transformed, as 0 scores cannot be transformed using a 
logarithmic transformation.  Additionally there has recently been much concern about the 
hazards of overfitting datasets (Babyak, 2004) which may create a situation in which 
effects are detected in the sample when they may not exist within the population. The 
concern for overfitting of data includes processes such as searching for confounds and 
statistically controlling for said variables, and conducting too many screening tests 
(Babyak, 2004).  The reason for this is that for each test, degrees of freedom are used up 
or “wasted” and they then become what Babyak calls “phantom degrees of freedom” 
which leads to increased risk of error.  Thus, it was decided to avoid some of the common 
methods of data cleaning (transformations and adjustments for excessive 
multicollinearity) in an effort to make sure the dataset was not overfit to the sample 
characteristics, as well as to account for the high frequency of “0” observations.  In spite 
of all of the concerns about transformation, I ran the analyses both ways (with the data 
transformed and with data unadjusted).  Running the analyses with the transformed data  
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did not change the pattern of findings.  Thus, given that there were no differences, the 
reported results are with the non-transformed data to account for the initial concerns.  
 
 
Statistical Analysis Plan 
Analyses were conducted as intent-to-treat with the “last measure carried 
forward” method.  This is deemed to be a relatively conservative method of data 
imputation as it assumes that there is no difference from the previous time of assessment.  
 
 
Analyses for Hypotheses Testing 
Hypothesis 1: There will be a significant difference between the ACT group and 
education group in post-intervention enmeshment as measured by the PRISM, after 
controlling for baseline enmeshment.  Means will reflect greater reductions in 
enmeshment for the ACT group than the control group.  This was tested using an 
ANCOVA to compare the means of each group on the post-intervention PRISM scores 
while controlling for baseline scores as the covariate.  There are several reasons why I 
chose this approach rather than opting for repeated-measures ANOVA, an ANOVA with 
change scores, or a one-way ANOVA.  Although many pre-post designs utilize repeated 
measures ANOVA, there are concerns with this approach, mainly that pretest scores are 
not influenced by the treatment when calculating the treatment main effect (Dimitriv & 
Rumrill, 2003) and so use of ANCOVA or ANOVA with change scores is advised.  The 
main advantage to using ANCOVA is that this method helps to reduce error variance.  
ANCOVA can also be conducted on a much smaller sample size than ANOVA of change  
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given that the pretest and posttest have the same amount of within-group variance (Van 
Breukelen, 2006). However, a potential drawback to ANCOVA is that as the difference 
between groups at baseline increases there is a greater likelihood of bias and greater 
measurement error (Van Breukelen, 2006).  A potential final option would be to test this 
hypothesis using a one-way ANOVA.  It can be argued that if groups demonstrate no 
significant differences at baseline, presumably due to successful randomization, then 
controlling for baseline is not necessary (Rausch, Maxwell, & Kelley, 2003).  However, a 
one-way ANOVA only assesses group differences at one point in time, in this case 
postintervention, and does not fully account for change in the variable of interest over 
time. Furthermore, according to Huck and McLean (1975; referenced in Rausch et al., 
2003) it is not advised to use this method “when pretest data is available…[because 
pretest data] should be used to a) adjust posttest means to account for initial differences 
between treatment groups and b) increase the power of the analysis by reducing within-
group variability” (Huck & McLean, 1975, pg. 513).  Based on all of the above reasons, 
ANCOVA controlling for baseline scores was deemed the most appropriate test for this 
hypothesis. 
Additionally, because the PRISM was used to measure several different FMS 
related constructs (Fibromyalgia, Pain, Fatigue, and Cognitive Symptoms/”Fibrofog”) a 
separate ANCOVA was conducted for each of these variables resulting in four separate 
analyses.  The use of MANCOVA was considered; however ultimately it was deemed 
inappropriate as MANCOVA would not allow for the control of individual baseline 
variables; rather all baseline variables would be controlled for as one unit.  This is not 
advised when using covariates as a method of controlling for baseline scores in a pre-post  
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analysis (personal communication, Matthew Poes, September 10, 2012).  MANCOVA 
also does not provide information on which group is greater, it only provides indication 
of group differences, thus resulting in more post-hoc tests and greater loss of power and 
degrees of freedom (person communication, Rich Ulrich, September 10, 2012).  
Furthermore, Huberty and Morris (1989) suggest that multivariate tests are appropriate 
for multivariate questions, whereas univariate tests are more appropriate for a series of 
univariate questions.  It is generally advised to conduct an adjustment (such as a 
Bonferroni adjustment) to prevent potential type I error when many tests are run (such as 
in the present analysis plan).  The Bonferroni adjustment is capable of reducing type I 
error through deflating the overall α applied to each test that is run (Perneger, 1998). 
Adjustments such as these may reduce type I error; however they increase type II error or 
the chance of falsely failing to reject the null hypothesis and failure to detect an effect 
that actually exists (Perneger, 1998).  In cases of very small sample size where detection 
of group differences is already challenging because of lack of power, an adjustment for 
type I error could potentially mask existing effects (Garamszegi, 2006).  Recent 
recommendations have suggested always providing effect sizes and/or confidence 
intervals to aid in determining the relevance and clinical significance of a given effect 
(Garamszegi, 2006).  Thus, it was decided to not include an adjustment for type I error.   
Prior to conducting the ANCOVA, an ANOVA was conducted to assess potential 
differences between treatment groups in enmeshment with symptoms at baseline.  The 
potential interaction between the covariate of the baseline enmeshment with FMS and 
group (the assumption of homogeneity of regression slopes) was then tested in order to 
assess any potential violations of the assumptions behind ANCOVA.  In cases in which  
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this assumption was met, ANCOVA was performed with the baseline score on the 
outcome measure as the covariate. 
Hypothesis 2: There will be a significant difference between the ACT group and 
education group in post-intervention acceptance of pain as measured by the CPAQ, after 
controlling for baseline acceptance.  Means will reflect greater increases in acceptance 
for the ACT group than the control group.  This was tested using an ANCOVA with 
baseline acceptance scores as the covariate and post-intervention acceptance scores as the 
dependent variable.  The same reasoning was used in determining the test for this 
hypothesis as with hypothesis 1.  
Hypothesis 3a & b: Acceptance of pain will mediate the relationship between 
treatment group membership and enmeshment.  This was tested using Hayes’ procedure 
for assessing mediation (Hayes, 2011).  There are several advantages to the bootstrapping 
method compared to the traditional Baron and Kenny (1986) method and the Sobel test.  
Bootstrapping is a computer-intensive type of resampling procedure that “creates an 
empirical estimate of the sampling distribution of the indirect effect” (Hayes, 2009, pg. 
7). According to Hayes (2009) the bootstrapping procedure treats the sample as a 
miniature representation of the population. Unlike the causal steps/Baron and Kenny 
method which determines the presence of an indirect effect by testing several hypotheses 
and applying the results to make a logical conclusion about the indirect effect, 
bootstrapping results in an estimate of the actual indirect (moderating or mediating) effect 
(Hayes, 2009).  Most importantly, the bootstrapping approach has greater power than 
both the Baron and Kenny method and the Sobel test (Hayes, 2009).  It should be noted 
that bootstrapping is considered to be one of the overfitting techniques cautioned against  
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by Babyak (2004).  So while some argue it has greater power and greater ability to detect 
effects within the sample (Hayes, 2009), these effects may not be relevant to the 
population and thus must be interpreted with caution (Babyak, 2004).  
 
 
Participants 
Demographic and study variable means and standard deviations are detailed in 
Tables 2 and 3.  The average age of participants was 48.63 (SD = 12.96).  Participants 
rated their average pain over the past week a mean of 7.21 (SD = 2.22) and their current 
pain M = 6.64 (SD = 2.02).  The average level of fatigue was 6.19 (SD = 1.76).  The 
majority of the sample was Caucasian (79.3%; African American 17.3%).  T-tests 
revealed no significant differences between groups on any demographic variables (see 
Table 3) nor on severity of pain or fatigue.   
 
 
Descriptive Analyses 
 
 
 
Baseline Scores 
Both the ACT and education group had similar scores at baseline; there were no 
statistically significant differences between treatment groups at baseline on any of the 
study variables (see Table 4). Both groups reported SIS scores showing moderate 
schema-enmeshment with FMS, pain, and other symptoms at baseline (see Table 5). It 
should be noted that there was a large range in SIS scores (see Table 5) indicating that
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some individuals were completely enmeshed with FMS or symptoms while others 
showed no enmeshment.  Baseline acceptance of pain scores were low for both groups 
(see Table 5).   
While SIS scores were generally low, it should be noted that the range and the 
variability or spread of the distribution was large, as demonstrated by the standard 
deviations.  Furthermore, while it may appear that there were great differences in 
schema-enmeshment with FMS between groups, the standard deviations were large and 
the sample size was small making it challenging to detect statistically significant 
differences. Considering that the score for CPAQ-Activity engagement is out of a total 
possible 110 points with greater scores indicating greater involvement in activity despite 
pain, these means show that at baseline individuals in both groups were not very active or 
not willing to participate in activities when in pain.  The CPAQ-Pain willingness score is 
out of a total possible 90 points with greater scores indicating more willingness to 
recognize that attempts to control pain are not fruitful, thus it would appear that at 
baseline individuals in both groups were making many unsuccessful attempts to manage 
or control the pain in maladaptive ways.  
 
 
Correlations at Baseline 
 Since there were no significant differences between the two treatment groups at 
baseline, and because of the fact that at this time the groups had not yet received any 
differential treatment, the correlations were conducted with the entire sample.  There was 
a large correlation between schema-enmeshment with FMS and schema-enmeshment 
with pain and fatigue.  This is not surprising given that these are two primary symptoms  
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of FMS.  There were no significant correlations between enmeshment with “fibrofog” 
and any other variable (see Table 6).  Significant moderate correlations were observed for 
the relationship between activity engagement and enmeshment with pain and fatigue (see 
Table 6).  These correlations suggest that lower levels of activity engagement are 
associated with greater levels of schema-enmeshment.  Pain willingness was also 
moderately correlated with schema-enmeshment with FMS.  This pattern of correlations 
is what would be expected based on the nature of the constructs and how they are 
theorized to relate to one another in a group of women with FMS.  What is noteworthy is 
that average weekly pain intensity was not significantly correlated with enmeshment with 
FMS (r = -0.19, p = 0.38).  However, average weekly pain intensity was correlated with   
enmeshment with pain (r = -0.42, p = 0.05).  Baseline fatigue was also not correlated 
with enmeshment with fatigue (r = -0.23, p = 0.28).  These results indicate that symptom 
severity is not necessarily predictive of enmeshment. 
 
 
Hypothesis Specific Results 
 
 
 
Hypothesis 1 
An ANCOVA was conducted to assess hypothesis 1: “There will be a significant 
difference between the ACT group and education group in post-intervention enmeshment 
as measured by the PRISM and if this difference is significant, means will reflect greater 
reductions in enmeshment for those in the ACT group”. The ANCOVA was used to 
compare the means of each group on the post-intervention schema-enmeshment while 
controlling for baseline scores as the covariate.
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Enmeshment with FMS 
There were no group differences at baseline (see Table 4), and the assumption of 
homogeneity of regression slopes was not violated.  An ANCOVA revealed that 
treatment groups were statistically significantly different at post-intervention (see Table 
7) after controlling for baseline scores. The main effect for group was small but 
significant, partial η² = 0.19 (see Table 7).  Although not necessarily indicated by the 
ANCOVA method, in order to have a better understanding of the changes observed for 
each group, the average mean reductions per group were examined.  It should be noted 
that this second approach serves more as a description of the changes in each group rather 
than a test of group differences at postintervention.  Upon examining the group mean 
reductions in enmeshment, the ACT group displayed greater reductions in enmeshment 
with FMS compared to the educational control group.  The ACT group displayed a 
reduction of –0.76 compared to only -0.49 in the control group.  It is curious that such a 
small difference between groups would be significant.  Thus, this hypothesis was also 
tested using the simple ANOVA method to account for the possibility of statistical error 
associated with the baseline as the covariate.  The results of the ANOVA indicated that 
there was a statistically significant difference between groups F(1, 24) = 6.27, p = 0.02.  
This will be further addressed in later sections.  However, it can be stated that in the case 
of enmeshment with FMS, hypothesis 1 was supported. 
 
 
Enmeshment with Pain 
 There were no group differences at baseline (see Table 4), and the assumption of 
homogeneity of regression slopes was not violated.  The ANCOVA revealed no  
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statistically significant group differences in enmeshment with pain at post after 
controlling for pre scores (see Table 7).  The ACT group reported a mean reduction of -
0.69 compared to a mean reduction of -0.13 in the control group.  Thus, hypothesis 1 was 
not supported in regard to schema-enmeshment with pain. 
 
 
Enmeshment with Fatigue 
 There were no group differences at baseline (see Table 4), and the assumption of 
homogeneity of regression slopes was not violated.  The ANCOVA to assess group 
differences in enmeshment with fatigue revealed statistically significant group 
differences (see Table 7). The main effect for group was small but significant, partial η² = 
0.26 (see Table 7).  As with schema-enmeshment with FMS, the average mean reductions 
per group were examined.  The ACT group reported a mean change in enmeshment with 
fatigue of -3.31 compared to a mean change of 0.63 in the control group.  Of note, the 
education group demonstrated a small increase in schema-enmeshment with fatigue. 
Thus, hypothesis 1 with regard to enmeshment with fatigue was supported. 
 
 
Enmeshment with Cognitive Symptoms/Fibrofog 
There were no group differences at baseline (see Table 4), and the assumption of 
homogeneity of regression slopes was not violated.  The ANCOVA revealed statistically 
significant differences in enmeshment with cognitive symptoms between groups (see 
Table 7).  The main effect for group was small but significant, partial η² = 0.29 (see Table 
7).  In order to have a better understanding of the changes observed for each group, the 
average mean reductions per group were examined, using the same method as for  
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schema-enmeshment with FMS and fatigue.  Once again, this approach is description of 
the changes in each group but it is not meant to serve as a test of group differences at 
postintervention.  Upon examination of the group mean reductions in enmeshment, an 
interesting pattern emerged.  The ACT group displayed reductions in enmeshment with 
cognitive symptoms (mean reduction of -5.02), whereas the control group displayed an 
increase (mean increase of 1.50).  Thus, hypothesis 1 was supported in regards to 
schema-enmeshment with cognitive symptoms. 
 
 
Secondary Analyses 
Secondary analyses were conducted to assess whether severity of symptoms 
changed as a result of the intervention; if this were the case then perhaps this change may 
have played a role in changes in enmeshment. Severity of symptoms (pain and fatigue) 
did not significantly change over time within groups (see means in Table 5), nor was 
there evidence of significant between group differences following the intervention (see 
Table 7).  In addition to the lack of movement in symptomology, the severity of these 
symptoms was not correlated with enmeshment with the respective symptoms. 
 
 
Hypothesis 2 
 An ANCOVA was conducted to test hypothesis 2: “There will be a significant 
difference between the ACT group and education group in post-intervention acceptance 
of pain as measured by the CPAQ and if this difference is significant, means will reflect 
greater increases in acceptance for those in the ACT group”.  The procedure that was 
used to test hypothesis 1 was used for hypothesis 2.  To test hypothesis 2, acceptance of  
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pain was assessed using both subscales of the CPAQ as they tap into different 
components of acceptance as a construct.  Thus, two different analyses were conducted in 
the examination of hypothesis 2. 
 
 
Acceptance of Pain: Activity Engagement 
There were no significant group differences in activity engagement at baseline 
(see Table 4); however, the assumption of ANCOVA was violated as the interaction 
between baseline activity engagement and group was statistically significant, F(1, 28) = 
6.807, p =0.015.  This significant interaction suggests that any group differences in the 
post-intervention score vary as a function of the covariate (in this case the baseline 
activity engagement) rather than the group. Further visual examination of the data via 
histograms of group scores revealed that although there was no significant difference in 
group means of activity engagement, the groups did in fact differ when it comes to the 
distribution of scores and this difference may have impacted the results of the test 
homogeneity of regression slopes.  Thus, when examining the data as an intent-to-treat 
analysis, I was not able to adequately test hypothesis 2 in regard to pain acceptance in the 
form of activity engagement.  
Because of the inability to test this hypothesis as an intent-to-treat analysis, the 
original dataset was used.  This time, the interaction between baseline activity 
engagement and group was not statistically significant, indicating the assumption of 
homogeneity of regression slopes was not violated.  The results of the ANCOVA, 
controlling for baseline activity engagement scores, revealed that treatment groups were 
statistically significantly different at post-intervention (see Table 7).  Upon examining the  
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group mean changes in activity engagement, the ACT group displayed greater changes in 
activity compared to the educational control group; the ACT group displayed a mean 
increase of 11.64 points compared to an increase of only 4.25 points in the control group.  
Thus, in the case of activity engagement hypothesis 2 was supported when examining the 
original dataset. 
 
 
Acceptance of Pain: Pain Willingness 
  There were no group differences at baseline (see Table 4), and the assumption of 
homogeneity of regression slopes was not violated.  The ANCOVA revealed that there 
were statistically significant group differences in pain willingness (see Table 7).  In 
looking at the group means, the ACT group increased in pain willingness by a mean of 
7.83, compared to the control group which experienced only a 0.50 change.  Thus, 
hypothesis 2 was supported for acceptance of pain in the form of pain willingness.   
 
 
Hypothesis 3 
The third research question was divided into two parts: a) Does activity 
engagement (acceptance of pain) mediate the relationship between group assignment and 
schema-enmeshment; b) “Does pain willingness (acceptance of pain) mediate the 
relationship between group assignment and changes in schema-enmeshment?”  It was 
hypothesized that both activity engagement and pain willingness would mediate the 
relationship between group membership and change in schema-enmeshment.  To test 
these hypotheses, change in schema-enmeshment with FMS, fatigue and cognitive 
symptoms were tested as separate outcome variables, resulting in three separate  
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mediation analyses for each hypothesis.  Only these three outcomes were chosen as they 
were the only outcomes with significant group differences at post-intervention according 
to the ANCOVA analyses. For these analyses, treatment group membership (ACT vs. 
educational control) served as a dichotomous independent variable and change in either 
activity engagement or pain willingness served as the mediator variable.   
To conduct these analyses, Hayes’ (2011) procedures for conducting mediation 
with a multicategorical independent variable were used; this includes the MEDIATE 
macro using SPSS.  Of note, when the independent variable is dichotomous it is treated 
as such by this macro. This procedure allows for the estimation of direct and indirect 
effects of all the variables in the model.  The procedure follows the bootstrapping 
methods mentioned previously. 
 
 
Does Activity Engagement Mediate Schema-Enmeshment with FMS? 
 The mediation approached statistical significance.  A significant indirect effect 
through change in activity engagement on change in schema-enmeshment with FMS was 
detected, β = 2.06, SE =1.45 (CI= 0.0067-5.4052; see Table 8). A confidence interval 
which does not include zero indicates that the effect is statistically significant, and that it 
can be stated with confidence that the effect was different than zero (Thompson, 2002).  
In the present analyses, although the confidence interval does not include zero, the lower 
limit of the confidence interval is approaching zero.  Thus, the results must be interpreted 
with caution, and may be considered a trend. 
A visual examination of correlations was conducted as a way to further examine 
the relationship between schema-enmeshment and acceptance.  This demonstrated that  
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the relationship between activity engagement and enmeshment with FMS was different 
for the two groups at post-intervention. For the ACT group the association scores are no 
longer significant at post-intervention (r = 0.18, p = 0.50; see Table 9) nor is the 
association between change scores significant (r = 0.44, p =0.09; see Figure 7). However, 
for the Educational control group the correlation demonstrates little change from baseline 
and it is still significant (r = 0.75, p = 0.03; see Table 10); the correlation between change 
in activity engagement and change in enmeshment with FMS is significant as well for 
this group (r = 0.74, p = 0.04).  This suggests that there is a lack of a relationship between 
activity engagement and schema-enmeshment with FMS among the ACT group; however 
this is a strong relationship indicating greater enmeshment is associated with less activity 
engagement for those in the educational control.  To test whether it was possible that 
schema-enmeshment was the mediating factor and that the directionality of the 
relationship was opposite of what was hypothesized, an exploratory mediation analysis 
was conducted with change in schema-enmeshment as the mediator and change in 
acceptance as the outcome.  This mediation was not significant, thus providing further 
support for change in acceptance as a mediating factor. 
 
 
Does Activity Engagement Mediate Schema-Enmeshment with Fatigue? 
 The same mediational analyses as conducted above showed that activity 
engagement did not mediate the relationship between treatment group and schema-
enmeshment with fatigue, β = 1.11, SE = 0.86 (CI= -0.10 – 3.22).
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Does Activity Engagement Mediate Schema-Enmeshment with Cognitive Symptoms? 
 The same mediational analyses as conducted above showed that activity 
engagement did not mediate the relationship between treatment group and schema-
enmeshment with cognitive symptoms, β = 1.15, SE =1.01 (CI= -0.46 – 3.59). 
 
 
Does Pain Willingness Mediate Schema-Enmeshment with FMS? 
 The same mediational procedure as conducted above was used to assess 
hypothesis 3b.  The mediation was not statistical significant, β = 1.47, SE =1.32 (CI= -
0.32 – 4.57).  This suggests that pain willingness does not mediate the relationship 
between treatment group and changes in schema-enmeshment with FMS. 
 
 
Does Pain Willingness Mediate Schema-Enmeshment with Fatigue? 
 The same mediational analyses as conducted above showed that pain willingness 
did not mediate the relationship between treatment group and schema-enmeshment, β = 
0.89, SE =1.13 (CI= -0.19 – 4.03). 
 
 
Does Pain Willingness Mediate Schema-Enmeshment with Cognitive Symptoms? 
 The same mediational analyses as conducted above showed that pain willingness 
did not mediate the relationship between treatment group and schema-enmeshment with 
cognitive symptoms, β = 0.43, SE =1.21 (CI= -1.89 – 3.22).
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Additional Analyses: Similarities with TST 
 The TST is one of the most widely used and accepted measures of self-concept 
(Grace et al., 2003).  In this test, participants are given 20 spaces to answer the question 
“Who am I?  In the present study, it was supposed that a moderate correlation between 
the TST and the PRISM might provide supporting evidence of the PRISM’s ability to 
detect self schema-enmeshment.  For example, if an individual listed “fibromyalgia 
patient” as one of the first self characteristics, we might assume that this person would 
also have a very low SIS score on the PRISM since the PRISM is intended to be a 
measure of the relationship between self and FMS.  Eight participants completed the TST 
(the addition of the TST was made after the majority of participants had been recruited).  
Of these eight, only 1 listed “fibromyalgia” as one of the 20 “self” descriptors.  None of 
the women listed any descriptor related to chronic pain, fatigue, or any other physical 
symptom.  The one woman who listed “fibromyalgia” as a descriptor listed it as number 7 
out of 20.  Given these limited findings, it would appear that among those who completed 
the TST there is not a relationship between the TST responses and the SIS scores on the 
PRISM.   
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DISCUSSION 
 
 
 
 The primary aim of this research was to examine the relation of illness with self, 
specifically the way in which FMS, pain and other symptoms become enmeshed in one’s 
self-schema.  This randomized controlled pilot study explored the implementation of 
ACT vs. a chronic pain self-management education intervention in 28 women with FMS.  
The study protocol specified that participants complete an average of eight, hour-long, 
individual sessions with a trained ACT therapist or FMS educator.  It was hypothesized 
that the women in the ACT group would experience greater reductions in schema-
enmeshment with all symptoms and greater increases in acceptance of pain compared to 
the women in the educational control group.  It was also hypothesized that should there 
be group differences in schema-enmeshment following the intervention, changes in 
acceptance would mediate the relationship between treatment group membership and 
changes in schema-enmeshment.  
 
  
Hypothesis 1: Self Schema-Enmeshment with Symptoms 
Hypothesis 1 postulated that there would be statistically significant group 
differences in schema-enmeshment with FMS, pain, fatigue, and cognitive symptoms 
following the intervention, and that the ACT group would experience greater reductions 
in schema-enmeshment with each of these constructs compared to the educational control 
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group.  Hypothesis 1 was supported when it came to schema-enmeshment with FMS, 
fatigue, and cognitive symptoms, but not pain.  
An interesting finding was the fact that there was a significant group difference in 
schema-enmeshment with FMS, when the reported difference in average reductions was 
relatively small (-0.76 for the ACT group and -0.49), accounting for a between groups 
difference of 0.27.  It is surprising that this small difference was statistically significant, 
especially given the small sample size of the study.  It should be pointed out that the 
analyses using the ANCOVA and the average mean change scores are two different 
approaches to the problem.  The ANCOVA effect size of partial η² = 0.19 is indicative of 
a very small yet significant group effect.  However, the mean different scores describe the 
difference from baseline to postintervention within each group.  Examination of the 
change scores and the difference between change scores provides a different type of 
information – one that is more descriptive than statistical - than the ANCOVA test.  Thus 
the mean reductions in schema-enmeshment should only be considered as another way to 
understand the data.  It should be noted that the two treatment groups were in fact 
different at baseline, although this difference was deemed non-significant (see Table 4), 
likely due to limited power.  Thus, in examining postintervention means in schema-
enmeshment with FMS, it may be that a small reduction may have been just enough 
change required to widen the gap between  groups, making it large enough to be detected 
with limited power. 
Although the effect size of the ANCOVA was small yet significant in nature, this 
does not imply that this difference is necessarily clinically significant. The self-illness-
separation score (SIS) on the PRISM is measured in centimeters.  The size of the radius  
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for the “self” disk is 3.5 cm and the size of the radius for the symptom disks is 2.5 cm 
(see Figure 2).  Thus even a small reduction in SIS could be clinically meaningful as a 
reduction of approximately 1 cm could completely eliminate overlap between the two 
disks.  For schema-enmeshment with FMS a mean reduction of -0.76 is likely not 
indicative of a statistically significant difference.  This is further evidenced by the fact 
that within group analyses of changes in schema-enmeshment were not significant for 
schema-enmeshment with FMS.  In the case of schema-enmeshment with fatigue, a mean 
reduction of 3.31 in the ACT group is meaningful as it implies little to no overlap 
between the self disk and fatigue disk, even for the most enmeshed person in the group.  
For schema-enmeshment with cognitive symptoms, a mean reduction of 5.02 implies that 
none of the participants reported any overlap between self and “fibrofog” disks.   
A plausible explanation for the changes in enmeshment with FMS and symptoms 
of fatigue and cognitive symptoms among the ACT group may lie in two of the core 
principles of ACT: defusion and self-as-context.  Defusion encourages individuals to 
remove the literality of thoughts and simply view them non-judgmentally, whereas self-
as-context teaches participants to experience the self as a stable perspective from which 
experiences (such as thoughts and feelings that are constantly changing) can be observed 
without becoming attached to them (Hayes et al., 2006).  Stated simply, people are not 
defined by their thoughts, feelings, or experiences.  Just because someone has fatigue this 
does not mean that they are the fatigue; fatigue is something that happened to them, not 
who they are as a person. When defusion and self-as-context are working together it may 
result in differentiating oneself from the experience of pain, fatigue or other symptoms 
and from thoughts about being a “FMS patient” or a person hindered by physical  
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symptoms.  Furthermore, defusion and self-as-context work often supports acceptance 
(Hayes et al., 2012) and may have led to other cognitive and behavioral changes which 
will be discussed in subsequent sections.   
 However, this does not explain why there were no group differences in schema-
enmeshment with pain.  The original premise was that as one became more accepting of 
the physical pain associated with FMS as simply an experience, then the more likely one 
would be to separate pain from their sense of self.  An interesting pattern of results 
emerges when looking at the amount of change in enmeshment with each symptom.  The 
greatest amount of change occurred for enmeshment with cognitive symptoms, followed 
by enmeshment with fatigue, then enmeshment with FMS, and finally no significant 
change in enmeshment with pain.  This is counterintuitive as pain is considered a primary 
symptom of FMS.  One possible explanation is that for some individuals, other symptoms 
(such as fatigue or cognitive symptoms) have been a bigger component of self than pain.  
In fact, 10 of 24 (41.7%) participants had greater or equal schema-enmeshment with 
fatigue at baseline than with pain.  Furthermore, although baseline ratings of pain 
intensity and fatigue intensity were essentially equal (see Table 5), interference ratings 
were discrepant.  Average fatigue interference was rated as a 6.07 (SD = 2.05) on the 
BFI; ratings greater than 7 indicate “severe fatigue” or more severe impairment in 
functioning (Mendoza et al., 1999).  Average FMS physical interference was rated as a 
1.40 (SD = 0.81) out of 3 on the FIQ-Physical Interference Subscale, indicating a 
moderate level of impairment from FMS symptoms.  This suggests that interference from 
fatigue may have been a greater concern than interference associated with FMS as a 
whole. There were no measures of pain interference, which might have clarified the  
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findings.  In accordance with ACT principles, if another symptom was causing the 
greatest amount of distress or the greatest impact on self then conversations in session 
may have focused more on fatigue or FMS as a whole rather than “pain”.  This is further 
evidenced in the larger effect sizes for cognitive symptoms and fatigue than FMS as a 
whole construct (see Table 7).  Post-study conversations with the ACT interventionists 
confirmed that often the focus of ACT exercises was not accepting the pain per se but 
accepting the experience of living with FMS (which includes the other associated 
symptoms).  
 A different potential explanation may be that perhaps prior to the intervention 
individuals reported lower levels of schema-enmeshment with pain because of avoidance 
of pain or denial rather than because of acceptance.  Interventionists reported that many 
participants reported using distraction techniques or other forms of avoidance to cope 
with pain.  This is consistent with work that demonstrates a high rate of pain avoidance in 
FMS populations (Bennett et al., 2007; Turk et al., 2004).  For example, in a sample of 
2569 women with FMS, 80% reported use of distraction techniques such as watching TV 
or reading to manage pain (Bennett et al., 2007).  If this were the case in this sample, then 
it is plausible that self and pain were not enmeshed, as pain was something to be actively 
avoided, in which case incorporating pain into one’s self schema would have been 
unlikely because of our desire to preserve a positive sense of self.  Of course, this 
possibility is speculative in nature and further study is warranted in order to better 
understand the changes in schema-enmeshment and cognitions over the course of the 
intervention.
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Hypothesis 2: Acceptance of Pain 
 Hypothesis 2 stated that there would be statistically significant group differences 
in changes in acceptance of pain, and that the ACT group would experience greater 
increases in pain acceptance than the control group.  Pain acceptance consists of activity 
engagement and pain willingness.   
Hypothesis 2 was supported for pain willingness.  These results indicate that the 
ACT group did report that their beliefs about experiencing pain had changed from before 
the intervention.  A significant change in pain willingness following the intervention is 
consistent with previous research on ACT for chronic pain (McCracken & Eccelston, 
2005; McCracken et al., 2005). When attempting to determine that magnitude of change 
for subscales such as this, Norman, Sloan, and Wrywich (2003) suggest a general 
principle that when changes are greater than half a standard deviation then they can be 
considered practically significant. A mean increase of 7.83 units in pain willingness for 
the ACT group is indicative of a change that is 2.46 units greater than half the standard 
deviation for the subscale (5.375).  Furthermore, analysis of within group data reveals a 
statistically significant difference from baseline to postintervention t(17) = 3.40, p ≤ 0.01, 
d = 0.80.  Taken together, the change in pain willingness can be interpreted as a large 
effect which is likely to reflect large clinical gains, especially when compared to the 
education group which demonstrated little to no movement in pain willingness (see Table 
5).   
Hypothesis 2 was also supported for activity engagement. However, for activity 
engagement this hypothesis was tested using the original dataset because when 
examining the intent-to-treat dataset, violations of assumptions surfaced. Since all other  
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analyses were conducted with the intent-to-treat dataset, these findings should be 
interpreted with caution.  Testing of the hypothesis showed that the ACT group 
experienced a large change in activity engagement (which was significantly different 
from baseline) and the educational group experienced only a small change (which was 
not significantly different from baseline).  Specifically, following the intervention, ACT 
participants were significantly more likely to continue to participate in various activities 
regardless of pain than they were prior to the intervention and in comparison to the 
educational control group. This is consistent with previous research of ACT and ABIs for 
various chronic pain conditions (McCracken & Eccelston, 2005; McCracken, Vowles, & 
Eccelston, 2005). A mean increase of 11.64 in activity engagement for the ACT group is 
also greater than half a standard deviation (5.36), indicating clinical significance when 
using the recommendations of Norman and colleagues (2003).  Within group analyses 
reveal statistically significant differences in activity engagement from baseline to 
postintervention, t (17) = 3.55, p ≤ 0.01, 0.84.  Thus, the change in activity engagement 
can be interpreted as large in effect and likely indicative of a clinically meaningful 
difference.   
The results of hypothesis 2 suggest that participants in ACT experienced changes 
in both the way they thought about the experience of pain and their attempts to control 
pain (pain willingness) and their ability to live an active life even in the presence of pain 
(activity engagement).  One of the core tenants of ACT is acceptance, which teaches that 
acceptance involves acknowledging and embracing internal experience (thoughts, 
feelings, bodily sensations) without attempting to change these when doing so would 
cause psychological harm (Hayes et al., 2006).  This may have translated into both more  
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pain willingness and more activity engagement, as an individual may be able to simply 
recognize she has pain without jumping to thoughts and behaviors that would be 
destructive (such as “I can’t play with my children today because it will hurt too much”).  
Equally important, ACT emphasizes committed action to work toward one’s identified 
values even in the presence of pain or challenging emotions or thoughts (Hayes et al., 
2012).  The intervention based on these principles may have led participants to behave in 
different ways which would then be reflected on the CPAQ.  These findings and 
interpretations are consistent with previous studies of ACT with chronic pain samples.  
Chronic pain patients receiving ACT  have demonstrated gains in both activity 
engagement and pain willingness as measured with the CPAQ (McCracken et al., 2008; 
Vowels & McCracken, 2008)  as evidenced by greater attendance at work (McCracken, 
1998) and less utilization of medical services (Dahl et al., 2004).  The core tenants of 
ACT may have played a role in the changes in acceptance of pain among those who 
participated in this arm of the study. 
 
 
Hypothesis 3: Acceptance of Pain as a Mediator 
 Hypothesis 3 proposed that changes in activity engagement and pain willingness 
would mediate the relationship between treatment group membership and changes in 
schema-enmeshment with each of the constructs that had significant group differences at 
post-intervention (FMS, fatigue, and cognitive symptoms).  Activity engagement only  
mediated the relation between group membership and schema-enmeshment with FMS.  
Pain willingness did not mediate any relationship between group membership and 
schema-enmeshment.
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The relation between activity engagement and schema-enmeshment with FMS at 
baseline appeared to be following the same pattern for both groups; greater enmeshment 
was associated with less activity engagement.  Individuals who are heavily enmeshed 
with FMS may come into activities with thoughts such as “I can’t do this because I have 
FMS”.  These thoughts then prevent them from engaging in life activities (Dahl & 
Lundgren, 2006).  Individuals who believe they cannot engage in life activities because 
of FMS symptoms, and therefore do not do anything, would observe their behavior and 
over time come to think of themselves as someone whose life is defined by FMS. This 
sequence of impact of cognitions on behavior is supported by both ACT (Dahl & 
Lundgren, 2006) and self-perception theory (Bem, 1972).  Following the intervention 
period of the study, the relation between activity engagement and enmeshment with FMS 
is different for each group; participants in the educational control group reported a 
relationship that closely resembled the relationship at baseline, i.e. there was no change 
(see Figure 7).  For the ACT group, however, the relationship between activity 
engagement and enmeshment is no longer there.   
One possible interpretation of these findings is that participants in the ACT group 
adopted ACT principles for living with their FMS.  They learned that no matter what they 
are experiencing cognitively or emotionally (such as thoughts consistent with schema-
enmeshment) they must still continue to work in service of their life values (Dahl & 
Lundgren, 2006; Hayes et al., 2012), thus possibly resulting in a stable level of activity 
engagement regardless of the level of schema-enmeshment present.  According to ACT 
principles, schema-enmeshment (fusion with thought) should not drive behavior; values  
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are what should direct behavior regardless of cognitive or physical obstacles (Dahl & 
Lundgren, 2006; Hayes et al., 2012).  It would appear that the findings are consistent with 
this idea and the overall principles of ACT. 
 The fact that activity engagement did not mediate the relationship between group 
and schema-enmeshment with fatigue as hypothesized is somewhat puzzling, as one 
might expect fatigue to be related to activity engagement, such that the more fatigue the 
less likely someone will be to participate in life activities.  The most reasonable 
explanation for the null findings for hypothesis 3 rests in the design of the activity 
engagement instrument.  The CPAQ was designed specifically to assess acceptance of 
pain (McCracken et al., 2004).  As pain is a symptom of FMS, but distinct from the 
others, the measure may have captured the mediation when asked about FMS but not 
symptoms distinct from pain. 
On the other hand, it is not surprising that activity engagement did not mediate the 
relationship between group and schema-enmeshment with cognitive symptoms, for 
several reasons.  First, as previously mentioned the measure was designed to assess the 
extent to which someone continues to participate in life activities despite pain, it does not 
specifically assess the impact of any cognitive symptoms on activity engagement.  
Secondly, it is plausible that the experience of memory difficulty, inattention, and 
confusion (all components of cognitive problems or fibrofog) would have less impact on 
physical activities compared to pain or other physical symptoms.  People with FMS have 
reported that cognitive challenges often create difficulty at work and in interpersonal 
relationships (which are not addressed in the measure of activity engagement), whereas  
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pain and fatigue are cited more often as interfering with physical activity (Arnold et al., 
2008).  It is worth mentioning that the ACT group did report significant reductions in 
cognitive symptoms compared to the control group; however the role of acceptance in 
creating this difference is not clear as “acceptance of cognitive challenges” or “cognitive 
activity engagement” was not directly measured. 
It is possible that pain willingness did not mediate the relationship between 
treatment group membership and schema-enmeshment with any construct due to 
measurement issues such as those addressed above.  The pain willingness subscale 
includes questions specifically targeted to willingness to experience pain without 
attempting to control it and does not address fatigue or cognitive symptoms.  It should 
also be noted that the lack of sufficient statistical power may have played a role in the 
non-significant findings.  It may also be that individuals pay more attention to behaviors 
that are associated with activity engagement (rather than lack of control behaviors which 
would be associated with pain willingness).  Thus attention to changes in  overt behaviors 
may be what is reflected upon by the patient and this in turn lead to changes in thoughts 
about the self in relation to pain and illness. However, this explanation is somewhat 
speculative in nature and greater study of the differences between activity engagement 
and pain willingness is warranted.  
 
 
Attempts to Explore Construct Validity of the PRISM 
  It is still a bit unclear as to what the PRISM really measures.  The present study 
attempted to compare the PRISM data with that of the TST to establish construct validity 
and the ability of the PRISM to assess schema-enmeshment of self and illness.  There  
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were several problems with this approach.  First, there was a lack of data to assess; only 
eight individuals completed the TST which severely limits the ability to make 
comparisons and detect similarities between the two measures.  Secondly, there is an 
issue of face-validity and social desirability.  The TST simply asks one to list 20 
responses to the statement “I am…” An individual may actively chose not to list 
“fibromyalgia patient” on the TST simply because they recognize that this may portray 
them in a negative light.  Many individuals with FMS state that they try not to advertise 
that they have FMS for fear that others will judge them or treat them differently as FMS 
is often stigmatized (Asbring & Narvenen, 2002; Stahl, 2001), which demonstrates the 
negative connotation that the label “fibromyalgia patient” carries.  Thus, even though the 
participants knew they were in a FMS study, they may have been unwilling to overtly 
define themselves in such a way.  This could be related to our innate desire to protect our 
sense of self and the phenomenon of self-enhancement in which we have an almost 
natural inclination to “maintain or increase the positivity (or decrease the negativity) of 
one’s self-concept [or] the desire to maintain, protect, and enhance one’s self-esteem” 
(Leary, 2007, pg. 319).  Humans go to great lengths to self-enhance including 
disregarding information that threatens their self-esteem and presenting themselves in 
ways that cast themselves more positively especially in relation to others (Leary, 2007).  
Taking all of this into consideration, it is possible that the TST was not the best choice of 
assessment to use as a measure of construct validity.   
Perhaps the PRISM is a less face-valid instrument which would provide a less 
threatening way for individuals to discuss their FMS and symptoms.  Interventionist 
notes and recordings demonstrate that individuals would often make statements which  
 76 
indicated that they clearly grasped how to complete the PRISM and what the constructs 
meant in relation to each other.  For example a participant who was completely enmeshed 
(placed the FMS disk directly on top of self: SIS = 0) stated “It’s all of me, it’s my whole 
life”.  This is also consistent with the work of Buchi and colleagues (2002) which found 
that 98% participants answered the PRISM in a manner that was aligned with the PRISM 
being a valid measure of the association of their self with illness. 
Importantly, in this study, the PRISM of FMS, pain, and fatigue was moderately 
correlated with activity engagement at baseline (see Table 5).  This pattern of results is 
consistent with what one might expect based on the cognitive- behavioral assumption that 
cognitions tend to drive behavior.  At baseline, none of the participants had been exposed 
to ACT ways of thinking which would emphasis less cognition-based action, thus an 
association between thought and reported behavior is not surprising.  This association is 
not seen at post intervention as some participants had been exposed to ACT.  Although 
this is not an example of construct validity, as it would have been if the PRISM and TST 
were highly correlated, it is at least encouraging that the results created by the PRISM are 
demonstrating the expected the pattern.   
Based on the limited data provided by this study, it cannot be concluded that the 
PRISM is a valid measure of sense of self; however it cannot be concluded that it lacks 
construct validity either.  Previous work suggests that the PRISM can  indeed detect 
relationships between the self and illness (Buchi et al., 2002; Denton et al., 2004; 
Kassardjian et al., 2008; Sharpe et al., 2006; Steiner, 2010) and that it is better correlated 
with other implicit or less face-valid ways of assessing self (Steiner, 2010).  Future large-
scale validity studies are needed to be able to definitively state that the PRISM is a  
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measure of schema-enmeshment of self and illness.  At this point, there does appear to be 
mounting evidence that the PRISM adequately assesses schema-enmeshment or at least a 
closely-related construct. 
 
 
Directions for Future Research 
 Several of the findings discussed above suggest directions for future research.  
Future research should further examine the role of acceptance in changes in schema-
enmeshment with fatigue.  In the present study enmeshment with fatigue was greater than 
enmeshment with the disease as a whole; additionally FMS patients often state that 
fatigue is one of the most challenging symptoms to manage (Soderberg & Lundman, 
2001).  However, fatigue is rarely discussed or studied as a main symptom and is 
generally treated as secondary to pain.  Thus studying individual’s ability to engage in 
life despite fatigue with a measure that is designed specifically to assess fatigue may 
yield important findings.  A review of the literature suggests that no such measure  
currently exists. It may be possible to simply modify the CPAQ by changing the word 
“pain” to “fatigue”; however this would have to be psychometrically validated before it 
could be used in research.   
Another potential area of research could be exploring and strengthening the 
validity of the PRISM as a measure of schema-enmeshment.  Some suggest it is the 
association between self and the burden of illness (Buchi et al., 2002; Buchi et al.,2000; 
Kassardjian et al., 2008), and some suggest it is another measure of schema-enmeshment, 
e.g. the association of the illness itself as a part of one’s self (Denton et al., 2004; Sharpe 
& Curran, 2006).  Part of the problem is a lack of clarity in the constructs themselves as it  
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could be argued that “schema-enmeshment of self and illness” and “association between 
self and the burden of illness” are the same construct. Although there has been some 
initial work in validating the instrument as a measure of schema-enmeshment, further 
study is warranted.  
A large area for future research would be the exploration of the processes or the 
mechanisms of change in behavior and relationship with thoughts associated with ACT.  
In the present study, activity engagement which is a form of pain acceptance was a 
predictor of group differences in change in schema-enmeshment with FMS.  However, 
activity engagement is really a behavior that is consistent with acceptance and other ACT 
principles.  It is not clear whether it is acceptance, defusion, commitment to action, or 
even a better understanding of self-as-context that is driving the changes seen in schema-
enmeshment.  Following several criticisms regarding the lack of research on the 
mechanisms of action in ACT (Arch & Craske, 2008; Asmundson & Hoffman, 2008) the 
literature is beginning to show a growth of interest in identifying the processes 
underlying change in ACT ( Hayes et al., 2010; Lundgren, Dahl, & Hayes, 2008; 
Wicksell et al., 2008). 
Although a great deal of the literature on ACT for chronic pain supports the 
notion that ACT creates changes in acceptance of pain as measured by the CPAQ (as 
seen in the present study), there is some competing evidence.  Wetherall and colleagues 
(2011) found that ACT did not produce any significant changes in acceptance compared 
to CBT, and that ACT participants did not significantly increase acceptance in 
comparison to those who received CBT.  It appears that research supporting ACT related 
changes in pain acceptance is limited to comparing ACT to control  or waitlist groups  
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(McCracken & Eccleston, 2005; McCracken et al., 2005) or lack a comparison arm 
(Vowles & McCracken, 2008).  Thus, although the results presented here are consistent 
with the majority literature stating that ACT is effective compared to controls, it is not yet 
clear that ACT is superior to existing evidence-based treatments.  Unfortunately, this 
study does not provide any additional information in regard to that question; future 
research should attempt to address whether results can be replicated in FMS when 
compared to interventions such as CBT. 
 Finally, a next step from this research may be to examine what types of behaviors 
and experiences (other than activity engagement) are associated with schema-
enmeshment.  Perhaps greater enmeshment is associated with more symptoms of 
depression, poorer quality of life, or greater difficulty in various life domains.  ACT has 
demonstrated efficacy in treating depression and increasing quality of life (Wetherall et 
al., 2011) in chronic pain populations; however depression and quality of life have not 
been examined as mediators of the relationship between FMS and its symptoms or in 
relation to schema-enmeshment.  Schema-enmeshment may act as another mediating 
factor or mechanism of change for depression or quality of life, and these potential 
relationships may be further explored.   
 
 
Clinical Implications for FMS 
The results of this study provide support for the use of ACT with individuals with 
FMS.  The data suggests that receiving ACT was related to increases in pain acceptance 
(particularly activity engagement) and reductions in schema-enmeshment.  This is an 
important finding as disability and submission to illness are common among those with  
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FMS (Kurtze, Gundersen, & Svebak, 2001; White, Birnbaum, Kaltenboeck, Tang, 
Mallet, & Robinson, 2008). These experiences may create or reinforce negative thoughts 
about the self, which in turn serve to solidify the enmeshment of self and illness, what 
Hayes et al. (2012) refer to as cognitive fusion.  Because ACT encourages activity 
engagement and working toward values-based goals regardless of pain (Vowles & 
McCracken, 2008), individuals with FMS may be able to break the cycle of disability 
which may change their thoughts about self, as demonstrated in the present study.  This is 
congruent with findings of Wicksell and colleagues (2008) who suggest that acceptance 
processes are responsible for changes in cognitive fusion with thoughts about pain and 
pain/disability behaviors (which could be thought to be related to schema-enmeshment).  
Thus, ACT appears to be an effective way to assist people with FMS to become active 
again and rebuild a life that is not defined by their illness. 
 Other potential clinical implications may lie in the relationship of schema-
enmeshment with quality of life or psychological well-being.  Low SIS scores on the 
PRISM have been correlated with depression (Buchi et al., 2002) and depression is a 
common concern in people with FMS (Gormsen, Rosenberg, Bach, & Jensen, 2010).  
Although it was not explicitly explored in the present study, reductions in schema-
enmeshment may be associated with reductions in depression and increases in well-being.  
Future research should aim to address this possibility. If this were the case, then ACT 
would be an intervention that could be used to target multiple aspects of living with FMS: 
disability, sense of self and psychological well-being. 
 81 
Future Directions for the PRISM: Clinical Utility Within an ACT Framework 
Although it is still unclear as to exactly what the PRISM measures, there may still 
be a good deal of clinical utility to this instrument.  As mentioned before, the PRISM is a 
less intrusive way of asking an individual the extent to which they have allowed their 
physical condition to become a defining aspect of self.  By going through the process of 
visually depicting the relationship between self and illness (rather than labeling oneself as 
the illness as one would with the TST) the individual may be more forthcoming or less 
susceptible to pressures of social desirability. 
Additionally, completing the PRISM task in the presence of an interventionist or 
therapist allows the task to serve as an opening for a conversation about the way in which 
fibromyalgia (or any other symptom or illness) has played a role in the individual’s life.  
The interventionists revealed that many times participants would place the disk on the 
board and spontaneously start to explain why it belongs in that place; however the 
interventionist could easily prompt the individual to explain.  Secondly, the PRISM was 
significantly moderately correlated with activity engagement as measured by the CPAQ-
AE at baseline, suggesting that schema-enmeshment of self and FMS and pain (see Table 
5) is associated with less activity.  Perhaps the PRISM is a good indicator of how 
behavior is related to enmeshment or the fusion with thoughts.  Using the PRISM and in 
conjunction with a measure of behavior (such as the CPAQ-AE) could be informative to 
the therapist but it could also be an illuminating moment of understanding for the client.  
This process could be very useful in a therapeutic setting, particularly during an intake or 
early session as a means of not only assessing the level of impact but also as a method of 
building a therapeutic alliance.
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Using the PRISM as a tool within the ACT framework may be especially 
appropriate.  ACT traditionally uses several elaborate metaphors and experiential 
activities to aid therapists and clients in developing a new perspective around the source 
of suffering (Hayes et al., 2012).  The PRISM is by definition a “hand-on”, experiential 
exercise and so it is consistent with other ACT practices and thus would not be out of 
place in an ACT session.  The tool itself could be used to further demonstrate several of 
the ACT tenets.  For example, if an individual places the “symptom” disk directly on top 
of the “self” circle and makes a statement such as “The pain has completely taken over 
my life; it’s who I am now”, then the ACT therapist may wish to use this to discuss 
cognitive fusion and how the individual is fused with this thought.  The therapist may 
then start to do defusion work.  Another perhaps even clearer use of the PRISM, may be 
to start self-as-context work.  In the given example, the therapist could explain to the 
individual that they are currently taking the experience of pain and literally defining their 
self within that context.  Self-as-context can be a difficult concept for people to 
understand and grasping the concept often requires a great deal of help from the therapist 
(Hayes et al., 2012), but the general principle is that “self” is a stable construct and 
experiences happen around it; the self is not the experience; in the case of chronic pain or 
FMS: you are not your illness.  By using the experiential PRISM exercise, therapists 
could explain how experiences happen around the “self” circle; this may help to clarify 
some of the more abstract aspects of self-as-context.  Finally, the PRISM could 
potentially be used to do values work.  In this case, the yellow circle would still be “self” 
but the other disks may represent valued life domains; the distance between self and the 
disks would then indicate how central certain values are to the individual or how  
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successful the individual has been in working accordingly with said values.  Importantly, 
if the PRISM were to be incorporated in an ACT practice, it does not have to be limited 
to identification of self and illness (as the instrument title suggests), it could potentially 
be used for any form of suffering. 
 
 
Limitations 
No study is without limitations.  The primary areas of concern for this study are 
the small sample size, concerns for external validity, concerns for internal validity, and 
lack of clarity in the constructs being assessed. 
It is well known that small sample sizes lack statistical power or the ability to 
detect significant effects should they be present (Keith, 2006).  Given that this study had 
a total sample size of only 28 participants, there is good reason to question the statistical 
power and ability to detect effects.  Yet, despite the small sample size, significant effects 
were detected.  There are two possible ways of explaining this situation.  Given the small 
sample size, and given that effects were found, the effects must be strong in magnitude to 
appear with such limited statistical power (Slavin & Smith, 2008).  Alternatively, it is 
possible that the detected effects are actually the result of statistical anomaly or type I 
error.  This second conclusion may be less likely when tests are run with the variables 
specified a priori with a strong theoretical rationale (as was done in the present study). 
This will reduce erroneous testing which increases risk for type I error (Babyak, 2004).  
Although the small sample size is recognized as a limitation, it should be noted that other 
pilot studies of ACT for chronic pain used even smaller samples (Dahl et al., 2004) and
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also found significant effects.  The present study serves as a pilot to assess the feasibility 
of this type of study for future research that will attempt to replicate these findings with a 
larger sample size. 
External validity, or the extent to which the results of a study can be applied to 
people and situations outside of the controlled study environment (Kazdin, 2002), is an 
area of concern for this study. First, this study used a sample of only women.  The 
decision to do this was based on the current statistics on FMS which indicate that 90% of 
those diagnosed with FMS are women (National Institute of Arthritis and 
Musculoskeletal and Skin Disease; NIAMS, 2011).  However, there are men who are 
diagnosed with FMS and the results may not be applicable to them.  Men may have very 
different ways of reacting to FMS and it is possible that they may have more or less 
schema-enmeshment of self with FMS then their female counterparts.  It is also plausible 
that men may have a different response to ACT procedures; however ACT has been used 
successfully for men in chronic pain before (Dahl et al., 2004; Wetherall et al., 2011).   
Related to the issue of external validity are the specific characteristics of the 
present sample that make them unique from the overall FMS population.  One of these 
characteristics is volunteer bias.  Although several methods of recruitment were used, a 
sizable portion of the sample were recruited from the database of individuals who have 
either previously participated in FMS research or those who have indicated that they are 
interested in participation.  It is possible that the women who were interested in 
participating in research are fundamentally different than those who choose not to 
become involved in FMS research.  All of the women in this study volunteered to 
participate which indicates a desire to try something new; this motivation may have  
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predisposed them to respond positively to treatment.  A large concern with volunteer bias 
is that it may have led to a sample that is substantially different from the population, 
making results difficult to generalize.  However, some researchers argue that volunteer 
bias is less of a concern in trials where participants agree to participate prior to 
randomization without knowledge of their group assignment (Tripep et al., 2010) as in 
this study.  
 Finally, women who screened positive for potential personality disorders were 
excluded from the study.  This could severely limit generalizability, as it estimated that 
7% of women with FMS also have a co-morbid personality disorder (Fietta, Fietta, & 
Manganelli, 2007).  Potential personality disorders were excluded from this study for two 
reasons: 1) personality disorders are long-standing and resistant to short-term treatment 
and could possibly derail the focus of an intervention aimed specifically at suffering 
related to a medical condition, 2) there is a small body of research that suggests that 
many of the co-morbid FMS/personality disorder diagnoses are inaccurate and that FMS 
can actually be reliably differentiated from Borderline Personality Disorder (Jochims et 
al., 2006).  Regardless, by excluding those with personality disorders, the results of this 
study may be applicable only to those without these types of disorders.   
 Although this study does pose some concerns related to internal validity, great 
precautions were taken to maximize validity.  One of the concerns with any intervention 
trial is the possibility of contamination from one condition to the other.  In order to guard 
against this, the educators received no training in the actual practice of ACT.  
Additionally, both interventions were manualized to facilitate fidelity to the intervention 
and all sessions were audio-recorded and audited for fidelity to the intervention.   
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Additionally, the ACT interventionists received weekly group supervision from an expert 
ACT therapist in order to ensure that treatment was consistent with ACT principles and to 
ensure uniform delivery of the intervention. 
 Another potential limitation is the fact that the PRISM was administered by the 
interventionists.  This is problematic for two reasons.  First, the study had several 
different interventionists and thus there is the possibility for systematic error in 
administration based on the natural presentation style of the interventionist.  Similarly, 
the interventionists were not blind to the participant’s group membership and it is 
possible that this information may have influenced administration of the measure.  Third, 
participants may have been inclined to respond in a manner that would indicate 
improvement out of desire to please their interventionist.  The first issue is less 
problematic as the instructions for the PRISM were scripted and all interventionists were 
trained in administration.  However, the possibility of biased responses due to 
interventionist administration is a valid concern.  Future studies should attempt to have a 
neutral member of the research team administer the PRISM or use a computerized 
version of the measure. 
 
 
Issues for Further Consideration 
It is not possible to conclude that ACT directly or definitively led to the 
reductions in schema-enmeshment among those who participated in that arm of the study, 
as we cannot completely rule out the contribution of variables or factors which were not 
measured or controlled.  However, it is logical to conclude that the intervention created 
this group difference as other factors (such as baseline level of enmeshment, and fidelity  
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to the intervention) were controlled by the researcher, and demographic factors were 
equal across groups due to randomization.  Additionally, in the cases of enmeshment with 
fatigue and cognitive symptoms, the ACT group reported enmeshment that was 
significantly different from that of their education counterparts.  This would suggest that 
changes in enmeshment were not simply due to common factors effects such as simply 
having the opportunity to talk with someone about FMS.   
The control condition may have impacted the results.  The educational control 
condition focused on providing pain self-management techniques; thus the participants in 
this group were receiving a type of active treatment.  This may be considered beneficial 
in that it creates equality between treatment groups on all variables except those of 
interest; however these techniques may have actually reinforced pre-existing thinking 
about pain.  It has been documented that FMS patients often feel that their condition is 
something to be managed (Arnold et al., 2008) and that patients are eager to learn new 
ways to alleviate or attenuate their symptoms (Bennett, 1996).  The educational condition 
may have created a greater affiliation with beliefs about controlling symptoms which may 
have translated into greater or at least sustained schema-enmeshment.  This emphasis on 
control is viewed as the problem within an ACT framework (Dahl & Lundgren, 2006), 
and it is actively discouraged in ACT.  It is possible then that the education group was 
“held back” by reinforcing control as the answer.  In essence, the control group may have 
actually served as the opposite treatment of ACT, rather than a neutral comparison, which 
may have led to group differences which would not have been seen otherwise. 
The validity of the PRISM as a measure of schema-enmeshment needs to be 
further studied.  As a test of validity, the present study attempted to compare the PRISM  
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to the TST.  There were several problems with this approach.  First, there was a lack of 
data to assess; only eight individuals completed the TST which severely limits the ability 
to make comparisons and detect similarities between the two measures.  Secondly, there 
is an issue of face-validity and social desirability.  The TST asks one to list 20 responses 
to the statement “I am…” An individual may actively chose not to list “fibromyalgia 
patient” on the TST simply because they recognize that this may portray them in a 
negative light.  Many individuals with FMS state that they try not to advertise that they 
have FMS for fear that others will judge them or treat them differently, as FMS is often 
stigmatized (Asbring & Narvenen, 2002; Stahl, 2001), which demonstrates the negative 
connotation that the label “fibromyalgia patient” carries.  Thus, even though the 
participants knew they were in a FMS study, they may have been unwilling to overtly 
define themselves in such a way. On the other hand, the PRISM instructions specifically 
asked about FMS and symptoms. Interventionist notes and recordings demonstrate that 
individuals would often make statements which indicated that they clearly grasped how 
to complete the PRISM and what the constructs meant in relation to each other.  For 
example a participant who was completely enmeshed (placed the FMS disk directly on 
top of self: SIS = 0) stated “It’s all of me, it’s my whole life”.  This is also consistent with 
the work of Buchi and colleagues (2002) which found that 98% participants answered the 
PRISM in a manner that was aligned with the PRISM being a valid measure of the 
association of their self with illness.  Taking all of this into consideration, it is possible 
that the TST was not the best choice of assessment to use as a measure of construct 
validity.  
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Based on the limited data provided by this study, it cannot be concluded that the 
PRISM is a valid measure of sense of self.  Previous work suggests that the PRISM can  
indeed detect relationships between the self and illness (Buchi et al., 2002; Denton et al., 
2004; Kassardjian et al., 2008; Sharpe et al., 2006; Steiner, 2010) and that it is correlated 
with other implicit or less face-valid ways of assessing self (Steiner, 2010).  Future large-
scale validity studies are needed to be able to definitively state that the PRISM is a 
measure of schema-enmeshment of self and illness.  At this point, there appears to be 
mounting evidence that the PRISM may adequately assess schema-enmeshment or at 
least a closely-related construct.  
Related to the above, there are several concerns related to the lack of clarity of 
both the constructs and the measures used in this study.  The measurement of self-
concept is notoriously difficult and schema-enmeshment is an abstract construct. The 
nature and language of ACT as a therapy modality contributes to the confusion.  ACT 
uses several terms that were created explicitly for ACT (e.g. defusion, self-as-context) 
and others that do not make intuitive sense (e.g. acceptance; psychological inflexibility).  
There is an ongoing discussion in the literature as to how to best measure certain 
constructs associated with ACT (Grossman, 2011).  In the present study, the PRISM was 
used primarily as a measure of schema-enmeshment, but schema-enmeshment can be 
thought of as equivalent to cognitive fusion with thoughts about FMS.  ACT 
conceptualization stresses fusion with maladaptive thoughts and behaviors (Hayes et al., 
2012), which could be interpreted as schema-enmeshment (as it was thought of here). 
Lack of clarity and lack of a unifying model of enmeshment are a limitation resulting
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from of the abstract constructs rather than study design.  Research needs to continue to 
attempt to clearly define these constructs, create ways to measures them in a valid 
manner, and develop a unifying model.   
 
 
Conclusions 
 This pilot study of a randomized controlled intervention of ACT for FMS was the 
first study to examine self schema-enmeshment with pain and illness in relation to ACT.  
The study provides encouraging evidence that ACT is capable of producing changes in 
self schema-enmeshment with the condition itself as well as two symptoms: fatigue and 
cognitive difficulties.  Importantly, the results indicated that ACT was capable of 
producing significant increases in acceptance of pain, specifically activity engagement.  It 
appears that changes in schema-enmeshment are related to changes in activity 
engagement, and activity engagement may actually be a mechanism of action for changes 
in enmeshment.  Thus, it seems that ACT shows promise for the treatment of FMS, 
specifically changes to one’s self-concept and the extent to which people allow their life 
and identity to be defined by FMS. 
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Table 1 
Timetable of Measures 
 
Construct 
 
Instrument 
 
Time of Administration 
 
Axis II eligibility Screener IOWA Personality Disorder 
Screen 
Screening 
Functioning eligibility 
Screener 
FIQ Screening 
Physical Functioning FIQ  Screening, Postintervention 
Demographics Project Questionnaire Baseline 
Pain VAS  Baseline, Postintervention  
Emotional Functioning PHQ  Baseline, Postintervention  
Pain Acceptance CPAQ Baseline, Postintervention  
Self-enmeshment with pain PRISM 1st and last session of 
intervention 
Self-concept TST 1st session of intervention 
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Table 2   
Demographic Characteristics of Patients 
 
Variable 
Means (SD)/ 
Frequencies 
(n = 28) 
 
Age of participants 
 
48.63 (12.96) 
 
Average current pain 
 
6.64 (2.02) 
 
Average pain over past week 
 
7.21 (2.22) 
Race/Ethnicity 
      White Non-Hispanic 
Black 
Other 
 
 
79.3% 
17.3% 
3.4% 
Education 
      High School Graduate or less 
Technical/Trade School/Some College 
      College Graduate or more 
      Completed Post Graduate  
 
 
18.5% 
44.4% 
25.9% 
11.1% 
 
Employment Status 
      Employed  
      Unemployed  
      Retired 
      Disabled 
      Other 
 
40.7% 
7.4% 
11.1% 
29.7% 
11.1% 
 
Annual Household Income 
      Below 10K 
      10-30  
      30K 
      40K 
      50K 
60 K 
>70K 
 
14.8% 
22.2% 
22.2% 
7.4% 
7.4% 
11.1% 
14.8% 
Marital Status 
      Married/Partnered 
      Divorced 
Single 
 
51.9% 
22.2% 
25.9% 
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Table 3  
Demographic Characteristics of Participants by Treatment Group 
 
Variable 
ACT 
(n = 18) 
Means (SD)/ 
Frequencies %  
 
Education 
 (n = 10) 
Means (SD)/ 
Frequencies %  
 
 
Group Comparisons 
 
Effect 
Size 
 
Age of participants 
 
47.82 (12.91) 
 
50.00 (13.62) 
 
t(26) = 0.42, p = .68 
 
d = 0.17 
     
 
Current Pain 
 
 
6.29 (2.32) 
 
7.30 (1.16) 
 
t(26) = 1.30, p =.21 
 
d = 0.53 
Average Pain 
 
7.00 (2.40) 7.60 (1.90) t(26) = 0.68, p = .50 d = 0.29 
Race/Ethnicity 
      White Non-Hispanic 
Non-white 
 
 
77.8 
22.2 
 
80.0 
20.0 
 
x² = (1, 27) = 0.45,  
p =  0.83 
 
 
ϕ = 0.04 
 
Education 
      Less than 4 years of college 
 College Degree 
 
 
66.7 
33.3 
 
60.0 
40.0 
 
x² = (1,27) = 0.06,  
p =  0.81 
 
 
ϕ = 0.05 
Employment Status 
      Employed  
      Not employed  
 
 
38.9 
61.1 
 
40.0 
60.0 
 
x² = (1,27) = 0.00 
p =  0.95 
 
 
ϕ= 0.01 
Annual Household Income 
      > 40K 
      < 40K 
 
 
61.1 
38.9 
 
60.0 
40.0 
 
x² = (1,27) = 0.00,  
p =  0.95 
 
 
ϕ= 0.01 
Marital Status 
      Married/Partnered 
      Not partnered 
 
61.1 
38.9 
 
40.0 
60.0 
x² = (1, 27) = 0.89,  
p =  0.35 
 
ϕ= 0.18 
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Table 4 
 Baseline Group Comparisons on Variables of Interest (t-test) 
 ACT ED Levene’s 
Test 
Test for 
equality of 
means 
Effect  
Size 
 M        SD M       SD  F p T Df P D 
PRISM FMS 5.56 6.38 2.65 3.17 3.29 0.08 0.92 22 0.24 0.38 
PRISM Pain 4.89 6.08 3.51 3.94 0.65 0.43 0.58 22 0.57 0.24 
PRISM Fatigue 4.05 4.29 3.74 4.43 0.21 0.65 0.17 22 0.87 0.07 
PRISM Fibrofog 4.90 4.08 5.45 4.05 0.17 0.69 0.31 22 0.76 0.13 
CPAQ-AE 35.83 17.09 30.20 11.98 0.58 0.46 0.92 26 0.37 0.38 
CPAQ-PW 22.39 11.00 25.40 10.79 0.08 0.81 0.70 26 0.50 0.29 
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Table 5 
Means and Descriptive Analysis Pre and Post-Intervention 
 Baseline M Baseline SD Post M Post SD 
ACT 
Pain (VAS) 5.95 2.34 5.00 2.10 
Fatigue (BFI) 5.84 1.96 4.72 2.02 
PRISM FMS 5.56 6.38 6.31 3.17 
PRISM Pain 4.89 6.08 5.58 3.31 
PRISM Fatigue 4.05 4.29 7.36 4.76 
PRISM Fog 4.90 4.05 9.92 6.30 
CPAQ AE 35.83 17.05 47.22 11.03 
CPAQ PW 22.39 11.00 30.22 10.75 
Educational 
Pain (VAS) 6.89 1.93 6.91 2.03 
Fatigue (BFI) 6.81 1.17 6.57 1.78 
PRISM FMS 2.65 3.17 3.14 2.35 
PRISM Pain 3.51 3.94 3.38 2.69 
PRISM Fatigue 3.74 4.43 3.11 2.77 
PRISM Fog 5.45 4.05 3.95 2.25 
CPAQ AE 30.20 11.98 33.50 14.62 
CPAQ PW 25.40 10.79 24.90 11.15 
 
 
 
 
 
 
  
Table 6  
Baseline Correlations Between the PRISM and CPAQ 
  CPAQ Pain 
Willingness 
 CPAQ 
Activity 
Engagement 
PRISM FMS  
SIS 
PRISM pain 
 SIS 
 PRISM 
fatigue SIS 
 PRISM Fog  
SIS 
 CPAQ Pain Willingness 1.00      
 CPAQ Activity Engagement 0.63** 1.00     
 PRISM FMS SIS 0.46* 0.56** 1.00    
 PRISM pain SIS 0.37 0.48* 0.82** 1.00   
 PRISM fatigue SIS 0.25 0.42* 0.75** 0.68** 1.00  
 PRISM Fog SIS 0.25 0.175 0.36 0.19 0.37 1.00 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed).  
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Table 7  
ANCOVA Results, Controlling for Baseline Scores 
 F Df P Partial η2 
Pain (VAS) 3.88 (1, 28) 0.06 0.13 
Fatigue (BFI) 3.96 (1, 28) 0.06 0.14 
CPAQ PW 4.22* (1, 28) 0.05 0.14 
CPAQ AE† 5.60* (1, 22) 0.03 0.23 
PRISM FMS 4.88* (1, 24) 0.04 0.19 
PRISM Pain 2.30 (1, 24) 0.14 0.01 
PRISM Fatigue 7.33** (1, 24) 0.01 0.26 
PRISM fog 8.41** (1, 24) 0.01 0.29 
*Significant at α <0.05 
**Significant at α < 0.01 
†Analysis was conducted using unaltered dataset as the intent-to-treat dataset did not meet statistical 
assumption 
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Table 8   
Mediation Results 
VARIABLES IN THE FULL MODEL: 
    Y = PRISM_FM 
   M1 = CPAQ_AE_ 
    X = Group 
================================================================== 
OUTCOME VARIABLE: 
   CPAQ-AE 
 
MODEL SUMMARY 
 
R 
 
R-sq 
 
Adj 
R-sq 
F 
 
df1 
 
df2 
 
p 
 
.3517 .1237 .0838 3.1047 1.0000 22.0000 .0920 
 
 MODEL COEFFICIENTS 
 Coeff. s.e. t 
 
P 
Constant -30.5000 11.8213 -2.5801 .0171 
Group 
 
8.7500 
 
4.9659 
 
1.7620 
 
.0920 
 
 ================================================================== 
OUTCOME VARIABLE: 
   PRISM SIS FMS 
 
MODEL SUMMARY 
 
R 
 
R-sq 
 
Adj 
R-sq 
F 
 
df1 
 
df2 
 
p 
 
.4634 .2148 .1400 2.8717 2.0000 21.0000 .0790 
MODEL COEFFICIENTS 
 Coeff. s.e. T p 
Constant 5.8933 6.2297 .9460 .3549 
CPAQ-AE .2356 .0984 2.3937 .0261 
Group 1.7931 2.4494 -.7321 .4722 
================================================================== 
INDIRECT EFFECT(S) THROUGH: 
 CPAQ-AE 
 Effect SE(boot) LLCI ULCI 
Group 
 
2.0619 
 
1.4460 
 
.0067 
 
5.4052 
 
  
Table 9 
Comparison of Correlations Pre and Post-intervention for ACT Group 
  CPAQ Pain 
Willingness 
CPAQ 
Activity 
Engagement  
 PRISM FMS 
SIS 
 PRISM pain 
SIS 
PRISM fatigue 
SIS 
PRISM Fog 
SIS 
Baseline 
CPAQ Pain Willingness 1.00      
CPAQ Activity Engagement Scale     0.66** 1.00     
PRISM FMS SIS  0.57*  0.563* 1.00    
PRISM pain SIS 0.34 0.460  0.67** 1.00   
PRISM fatigue SIS 0.35 0.387  0.73**     0.71** 1.00  
PRISM Fog SIS 0.45 0.321 0.55* 0.30 0.42 1.00 
Post-intervention 
CPAQ Pain Willingness 1.00 0.41 0.10 0.28 0.12 0.14 
CPAQ Activity Engagement Scale   1.00 0.18 0.41 0.40 0.40 
PRISM FMS SIS   1.00 0.51* 0.28 0.24 
PRISM pain SIS    1.00 0.16 0.01 
PRISM fatigue SIS     1.00 0.59* 
PRISM Fog SIS      1.00 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
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Table 10 
Comparison of Correlations Pre and Post-intervention for Education Group 
  CPAQ Pain 
Willingness 
CPAQ 
Activity 
Engagement  
 PRISM FMS 
SIS 
 PRISM pain 
SIS 
PRISM 
fatigue SIS 
PRISM Fog 
SIS 
Baseline 
CPAQ Pain Willingness 1.00      
CPAQ Activity Engagement Scale    0.74* 1.00     
PRISM FMS SIS 0.38 0.70 1.00    
PRISM pain SIS 0.40 0.55  0.83* 1.00   
PRISM fatigue SIS 0.07 0.63    0.85** 0.49 1.00  
PRISM Fog SIS -0.24 -0.37         0.31 0.25 0.29 1.00 
Post-intervention 
CPAQ Pain Willingness 1.00    0.79** 0.21 -0.00 -0.02 -.083* 
CPAQ Activity Engagement Scale   1.00  0.75* 0.61 0.58 -0.62 
PRISM FMS SIS   1.00    0.93** 0.83* -0.07 
PRISM pain SIS    1.00   0.87** 0.17 
PRISM fatigue SIS     1.00 0.26 
PRISM Fog SIS      1.00 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
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Pain Illness
Self
Normal Enmeshment
Pain Illness
Self
Complete Enmeshment (Unhealthy) 
 
Figure 1.  Enmeshment of Pain, Illness, and Self Schemas (adapted from Pincus and 
Morley, 2001) 
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Figure 2.  The PRISM 
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Figure 3.  Hexaflex (adapted from Hayes et al, 1999).  Descriptions of ACT tenets 
adapted with permission of Rhonda Merwin, Ph.D. 
 
 
  
Acknowledging and 
embracing internal 
experience (thoughts, 
feelings, bodily 
sensations) without 
attempting to change 
these events 
Defusion without over-
identifying with a thought or 
responding to a thought in a 
literal way (i.e., as a literal 
truth).  exercises separate 
words from the events they 
represent; allows patients to 
cognitively distance from 
deeply held beliefs about pain 
and self as defined by pain).  
This permits patients to 
recognize compelling 
thoughts as verbal 
constructions of the world  
Patients experience the self as a 
stable perspective from which 
ever-changing events (such as 
thoughts and feelings that are 
constantly changing) can be 
observed 
Patients practice aligning current 
activities with how they personally 
define a vital life.  
 
Patients define what is 
personally meaningful in key 
life domains and evaluate 
their behavior as 
helpful/unhelpful in terms of 
these values 
Patients are taught to focus on the 
present moment rather than investing 
unnecessary energy in dwelling on the 
pain of the past or feared future.   
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Figure 4.  Hypothesized Mediation Model
Dichotomous independent 
variable 
ACT 
Educational 
Control 
Change in Acceptance 
of Pain  
(CPAQ) 
Change in 
Enmeshment 
(PRISM) 
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Figure 5.  CONSORT Chart
Contacted ≈ 435 
No answers = 119 
Messages left = 239 
Actual contact ≈ 77 
Assessed for Eligibility (Screened) 
N ≈ 56 
Randomized to Ed. Control 
N = 15 
(1 had been scheduled but never 
completed never showed up; 4 
opted out) 
Randomized to ACT 
N = 18 
 
Eligible for Participation 
N ≈ 37 
Completed Baseline 
N = 18 
 
Completed Baseline 
N = 10 
Completed Intervention and Post 
Assessment 
 
N = 9 
(1 withdrew after consent) 
 
Completed Intervention and Post-
Assessment 
 
N = 15 
(2 withdrew: 1 lost interest, 1 
injured; 1 removed due to PD) 
Completed 12 week Follow-up 
N = 9 
 
Completed 12 week Follow-up 
N = 15 
 
Provided Verbal Consent 
N = 33 
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Figure.6  Flow Chart of Study Protocol
Expressed interest in 
study 
Screening 
Qualify for 
participation 
Disqualified 
 (low FIQ or possible 
Axis II) 
Contacted and 
scheduled for 
sessions 
Randomized to 
treatment condition 
Completes baseline 
questionnaire online 
Intervention 
Completes post-
intervention 
questionnaire online 
Completes follow-up 
questionnaire online 
*PRISM administered during first and 
last session 
12 weeks of no contact 
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Figure 7.  Change in the Relationship Between CPAQ-Activity Engagement and PRISM 
FMS by Group 
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Appendix A 
Script for Recruitment Calls for Participants Off FMS Registry 
Hello XXX, My name is (Silvia Bigatti, Jennifer Steiner) and I am calling you from the Indiana University 
School of Medicine to invite you to be part of a study for fibromyalgia patients.  You are specifically 
being called because you (have asked to be added to the Rheumatology Research List/have responded 
to advertisements regarding this study).  Do you have time right now to hear about our study and 
decide whether you would like to participate? (If not, schedule a call back time).  If yes:  This is a study 
being conducted by Silvia Bigatti, who is in the Department of Public Health and a team of researchers 
who would like to determine whether an intervention  we have designed is useful for fibromyalgia.  If 
you agree to be part of the study, you will be expected to complete a battery of questionnaires before 
therapy, immediately after therapy, and again 3 months later.  The surveys can be completed in person 
or online, whatever you prefer.  Also, you will be expected to attend weekly individual  sessions in our 
offices for 8 weeks.  These sessions will last from 45-60 minutes and will be scheduled at your 
convenience. You would have to agree to be randomly assigned to one of two types of interventions, 
and once assigned randomly, you cannot be move into the other group.  In order to participate,  you 
would have to agree to this random assignment.  Are you able to do all this?  (If no, thank them and 
hang up).   
If so: Now I am going to send you a brief questionnaire to complete online to see if you can be a part of 
the study.[if the person indicates they do not have internet access then offer to complete the eligibility 
screening on the phone.  With permission proceed to below]   
*If completing on the phone First of all, has your fibromyalgia been diagnosed by a physician?  (If no, 
tell her we can’t include her, thank her, and hang up).  If so:  Do you remember who it was and what 
month and year?  Also, are you willing to stay on the same medications and doses for any 
antidepressants you are taking?  (If no….) If yes:  Are you able to read and write in English?; Are you 
between 18 and 65 years of age?  Do you have other rheumatic conditions?  Which?  Have you been 
diagnosed with schizophrenia or other psychosis?  Have you been diagnosed with cognitive impairments 
or dementia? (If no to all this, continue) 
I would like to administer a questionnaire to you at this point to see how the fibromyalgia is impacting 
your daily life.  I will ask you a few questions and let you follow up with the answers…(administer the 
FIQ). 
I would also like to ask you a few questions about how you are in everyday life (administer IOWA PD 
Screener) 
In the end, let participants know whether they are eligible or not and ask them, if eligible, whether they 
prefer hard-copy or online completion of surveys. 
If not eligible: “Unfortunately we cannot include you in the study, because of this we will remove all 
identifying information from the questions we just asked you, so you do not need to worry about loss of 
confidentiality.  We will make a note that you didn’t qualify, that way we do not contact you again.  
Thank you for your time and interest in the study.”
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Appendix B 
Brief Fatigue Inventory (BFI) 
Through our lives, most of us have times when we feel very tired or fatigued.  Have you felt unusually 
tired or fatigued in the last week?  Yes________  No_________ 
 
Please rate your fatigue (weariness, tiredness) by circling the one number that describes: 
 
1) Your fatigue right now 
 
0 1 2 3 4 5 6 7 8 9 10 
No           As bad as 
Fatigue                   you can 
imagine  
2) Your USUAL level of fatigue during the past 24 hours 
 
0 1 2 3 4 5 6 7 8 9 10 
No           As bad as 
Fatigue                   you can 
imagine  
3) Your WORST level of fatigue during the past 24 hours 
 
0 1 2 3 4 5 6 7 8 9 10 
No           As bad as 
Fatigue                   you can 
imagine  
4) Circle the one number that describes how, during the past 24 hours, fatigue has interfered 
with your: 
a. General Activity 
0    1 2 3 4 5 6 7 8 9 10 
Does not interfere        Completely 
Interferes          
b. Mood 
0    1 2 3 4 5 6 7 8 9 10 
Does not interfere        Completely 
Interferes 
c. Walking ability 
0    1 2 3 4 5 6 7 8 9 10 
Does not interfere        Completely 
Interferes 
d. Normal work (includes both work outside the home and daily chores) 
0    1 2 3 4 5 6 7 8 9 10 
Does not interfere        Completely 
Interferes 
e. Relations with other people 
0    1 2 3 4 5 6 7 8 9 10 
Does not interfere        Completely 
Interferes 
f. Enjoyment of life 
0    1 2 3 4 5 6 7 8 9 10 
Does not interfere        Completely 
Interfere 
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Appendix C 
Scripted Instructions for the PRISM (adapted from Buchi and Sensky, 1999) 
We would like to understand better how your Fibromyalgia affects your life at the moment.  I’d 
like you to imagine that this white board represents your life as it is now. 
 
The yellow disk in the bottom right corner represents your “self,” and this red disk represents 
your Fibromyalgia. 
 
Where would you put your Fibromyalgia—the red disk—in your life at the moment? [Hand red 
disk to patient] 
 
Most people have an intuitive idea of where to place the illness disk, but if someone does not 
appear to understand the above instructions, go to those below: 
 
As this may be a rather unusual way of showing the place of your illness in your life, let me give 
you another example.  The blue disk represents your work or your job. For some people, work is 
an essential part of their lives and makes all the difference in how they see themselves. Such a 
person would put the “Work” disk on top of the “Self” disk [demonstrate this]. For other people, 
work is not that important. For example, they may work just to earn money. Such a person would 
place the “Work” disk quite far from the “Self” disk [demonstrate]. 
 
Where would you put your Fibromyalgia—the red disk—in your life in relation to yourself at the 
moment ? [Hand red disk to patient] 
 
Measure the distance between the centers of the two disks—the Self-Illness Separation (SIS)using 
the ruler provided.  Record this distance in  centimeters on the PRISM record form. 
Repeat the process for each of these aspects of the disease: 
Green disk: Where would you put your pain—the green disk—in your life in relation to yourself 
at the moment? [Hand green disk to patient] 
 
Orange disk: Where would you put your fatigue—the orange disk—in your life in relation to 
yourself at the moment? [Hand orange disk to patient] 
 
Purple disk: Where would you put your “fibro fog” (memory problems, feeling like mind is 
“fuzzy”)—the purple disk—in your life in relation to yourself at the moment? [Hand purple disk 
to patient] 
 
Any other disk: Now I’d like you to pick any other part of your Fibromyalgia that plays an 
important role in your life and make it this disk [Hand disk to patient] Where would you put this 
in your life in relation to yourself at the moment? 
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Appendix D 
Fibromyalgia Impact Questionnaire (Burckhardt, Clark, and Bennett, 1991) 
Were you able to: 
 a. Do shopping 0 1 2 3 
 b. Do laundry with a washer & dryer 0 1 2 3 
 c. Prepare meals 0 1 2 3 
 d. Wash dishes/cooking utensils by hand 0 1 2 3 
 e. Vacuum a rug 0 1 2 3 
 f. Make beds 0 1 2 3 
 g. Walk several blocks 0 1 2 3 
 h. Visit friends or relatives 0 1 2 3 
 i. Do yard work 0 1 2 3 
 j. Drive a car 0 1 2 3 
 
2.  Of the 7 days in the past week, how many days did you feel good? 
 1 2 3 4 5 6 7 
 
 
3.  How many days in the past week did you miss work because of your fibromyalgia? 
 0 1 2 3 4 5 I don’t work outside the home 
 
For the following questions, please mark the point on the line that best describes your feelings for 
the past week: 
 
4.  When you did go to work, how much did pain or other symptoms of your fibromyalgia 
 interfere with your ability to do your job? 
0_______________________________________________10 
 No problem Great difficulty 
  
1.  Please mark the category on the scale that best describes how often you were able to engage in th  
activities listed over the past week: 
 Always Most Times Occasionally Neve   
 129 
5.  How bad has your pain been? 
0_______________________________________________10 
 No pain Very severe pain 
 
 
6.  How tired have you been? 
0_______________________________________________10 
 No tiredness Very tired 
 
7.  How have you felt when you got up in the morning? 
0_______________________________________________10 
 Awoke well rested Awoke very tired 
 
 
8.  How bad has your stiffness been? 
0_______________________________________________10 
 No stiffness Very stiff 
 
9.  How tense, nervous or anxious have you felt? 
0_______________________________________________10 
 Not tense Very tense 
 
10.  How depressed or blue have you felt? 
0_______________________________________________10 
 Not depressed Very depressed  
 
Scoring Instructions: 
• Item 1: Average the 10 scores from the items listed as Item 1     
A+B+C+D+E+F+G+H+I+J/10    ______ + 
• Item 2: Reverse score  (if 3, write 5)  ______ +  
• Item 3: Copy score from above (if 3, write 3)  ______  + 
• Add scores from Items 4-10   _______+ 
• Add each of these steps for Total Score  
                                                                           = _____
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Appendix E 
 
Chronic Pain Acceptance Questionnaire (McCraken, Vowles, & Eccelston, 2004) 
INSTRUCTIONS: Below you will find a list of statements.  Please rate the truth of each 
statement as it applies to you.  Use the following rating scale to make your choices. For 
instance, if you believe a statement is ‘Always True,’ you would write a 6 in the blank next 
to that statement 
Never 
True 
Very 
Rarely 
True 
Seldom 
True 
Sometimes 
true 
Often 
true 
Almost 
always 
true 
Always 
true 
0 1 2 3 4 5 6 
 
1. I am getting on with the business of living no matter what my level of pain is ……… 
2. My life is going well, even though I have chronic pain……… 
3. It’s OK to experience pain ……… 
4. I would gladly sacrifice important things in my life to control this pain better ……… 
5. It’s not necessary for me to control my pain in order to handle my life well ……… 
6. Although things have changed, I am living a normal life despite my chronic pain ……… 
7. I need to concentrate on getting rid of my pain ……… 
8. There are many activities I do when I feel pain ……… 
9. I lead a full life even though I have chronic pain……… 
10. Controlling pain is less important than any other goals in my life ……… 
11. My thoughts and feelings about pain must change before I can take important steps in my life 
12. Despite the pain, I am now sticking to a certain course in my life ……… 
13. Keeping my pain level under control takes first priority whenever I’m doing something  
14. Before I can make any serious plans, I have to get some control over my pain ……… 
15. When my pain increases, I can still take care of my responsibilities ……… 
16. I will have better control over my life if I can control my negative thoughts about pain  
17. I avoid putting myself in situations where my pain might increase ……… 
18. My worries and fears about what pain will do to me are true ……… 
19. It’s a relief to realize that I don’t have to change my pain to get on with my life ……… 
20. I have to struggle to do things when I have pain……… 
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Appendix F 
 
The Twenty Statements Test (TST) 
 
There are twenty numbered blanks on the page below. Please write twenty answers 
to the simple question "Who am I?" in the blanks. Just give twenty different answers 
to this question. Answer as if you were giving the answers to yourself, not to 
somebody else. Write the answers in the order that they occur to you.  
I am: 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
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schizophrenia   
 134 
Peer- Reviewed Publications 
 
Steiner, J.L., Bogusch, L., & Bigatti, S.M.  (in press).  The association of Acceptance 
and Commitment Therapy and success in life values in fibromyalgia. Health 
Psychology Research. 
 
Dir, A., Coskupinar, A., Steiner, J.L.,  & Cyders, M. (in press).  Personality and social 
learning predictors of sexting: Development of the sexting behaviors scale and the 
sextpectancies measure. Cyberpsychology, Behavior, and Social Networking. 
 
Ang, D.C., Jensen, M.P., Steiner, J.L., Hilligoss, J.,  Graceley, R.M., & Saha, C.   
(2013). Combining cognitive behavioral therapy and milnacipran for 
fibromyalgia: A feasibility randomized-controlled trial. The Clinical Journal of 
Pain. 
 
Bigatti, S.M., Steiner, J.L., & Miller, K.D. (2012).  The role of cognitive appraisals and 
coping in psychological distress in advanced breast cancer patients.  Stress and 
Health, 28(5), 355-361. 
 
Bigatti, S.M., Steiner, J.L., & Cronan, T.A. (2012). Rates of depression and anxiety in 
cancer patients: A review of cross-national findings. Praxis Klinische 
Verhaltensmedizin und Rehabilitation (Practice of Clinical Behavior Medicine 
and Rehabilitation). 
 
Bigatti, S.M., Steiner, J.L., Makinabakan, N. Hernandez, A.M., Johnston, E., & 
Storniolo, A.M.  (2011). Matched and mismatched appraisals in patients with 
breast cancer and their partners: Implications for psychological distress.  Psycho-
Oncology.  DOI: 10.1002/pon.2028 
 
Bigatti, S.M., Brown, L.F., Steiner, J.L., & Miller, K.D. (2011).  Breast cancer in a wife: 
How husbands cope and how well it works.  Cancer Nursing, 34(3), 193-201.   
DOI:10.1097/NCC.0b013e3181ef094c. 
 
Bigatti, S.M., Wagner, C.D., Lydon, J.R., Steiner, J.L., & Miller, K.D.  (2011). 
Depression in husbands of breast cancer patients: Relations to coping and social 
support.  Supportive Cancer Care, 19(4), 455-466.  DOI 10.1007/s00520-010-
0835-8. 
 
Steiner, J.L., Hernandez, A.M., Lydon, J.R., Johnson, E., & Bigatti, S.M.  (2010). Role 
strains and marital satisfaction in husbands of patients with fibromyalgia 
syndrome.  Family Systems and Health, 28(3), 209-233.  
 
Ang, D.C., Chakr, R., Mazzuca, S., France, C.R. Steiner, J.L., & Stump, T.  (2010). 
Cognitive-behavioral therapy attenuates nociceptive responding in patient with 
fibromyalgia: A pilot study.  Arthritis Care and Research, 62(5), 618-623.   
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Manuscripts Under Review 
 
Ang, D.C., Saha, C., Steiner, J.L., Jensen, M.P., Graceley, R.M., & Hilligoss, J.  (under 
review). Combining cognitive behavioral therapy and milnacipran for 
fibromyalgia: A feasibility randomized-controlled trial. 
 
Steiner, J.L., Bigatti, S.M., & Ang, D.C. (under review). Trajectory of change in pain, 
depression, and physical functioning after physical activity adoption in 
fibromyalgia 
 
Invited Publications 
 
Bigatti, S.M. & Steiner, J.L. (in press).  Appraisal of Caregiving Scale.  In Encyclopedia 
of Quality of Life Research. 
 
Paper and Symposium Presentations  
 
Bigatti, S.M., Steiner, J.L., & Cronan, T.C. (2011).  Worldwide rates of distress in 
cancer patients: A review.  Paper presented at the Conference on Cancer Across 
the Continuum sponsored by the Borchard Foundation, Missillac, France. 
 
Bigatti, S.M., Steiner, J.L., & Cronan, T.C. (2011).  Dying well.  Paper presented at the 
Conference on Cancer Across the Continuum sponsored by the Borchard 
Foundation, Missillac, France. 
Steiner, J.L., Bigatti, S.M., Merwin, R.M., & McCracken, L.M. (2010). Acceptance and 
commitment therapy for fibromyalgia syndrome. In S. A. Johns (Chair), 
Innovative acceptance-based approaches to the assessment, conceptualization, 
and treatment of complex medical and mental health problems. Symposium 
conducted at the 44th Annual Convention of the Association for Behavioral and 
Cognitive Therapies, San Francisco, CA. 
Wagner, C.D., Steiner, J.L., Storniolo, A.M., & Bigatti, S.M.  (2009).   Patients and 
spouse cognitions in advanced breast cancer: implications for treatment.  Paper 
presented at the annual 2009 conference of the International Psycho-Oncology 
Society. 
 
Tallman, E.F., Steiner, J.L., Bigatti, S.M. (2009). Our illness: Husbands of fibromyalgia 
women report marital satisfaction and changes in sexual activity since the onset 
of chronic illness. Paper presented at Transcending Boundaries in Sexuality 
Research: Bridging Disciplines & Communities. National Sexuality Resource 
Center, Indiana University Bloomington, April 27, 2009. 
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Poster Presentations  
 
Bigatti, S.M., Steiner, J.L., Merwin, R.M., & McCracken, L.  (2013). Acceptance and 
Commitment Therapy Improves Depression Symptoms in Fibromyalgia 
Syndrome.   Poster to be presented at the annual 2013 conference of the 
International Association for Women’s Mental Health, Lima Peru. 
 
Ang, D.C., Jensen, M.P., Steiner, J.L., Hilligoss, J., Gracely, R., & Saha, C.  (2012).  
Cognitive Behavioral Therapy and Milnacipran in Combination Appears to Be 
More Efficacious Than Either Therapy Alone.  Poster session  presented at the 
2012 American College of Rheumatology/ARHP Annual Meeting,  Washington, 
D.C. 
 
Bigatti, S.M., Steiner, J.L., Merwin, R.M., & McCracken, L. (2012).  Acceptance and 
commitment therapy for fibromyalgia  syndrome.  Poster session presented at the 
annual International Congress of Behavioral Medicine, Budapest, Hungary. 
 
Steiner, J.L., Bogusch, L., & Bigatti, S.M.  (2012). Success in living a valued life: 
Acceptance and commitment therapy for fibromyalgia.  Poster session presented 
at the annual IUPUI Research Day, Indianapolis, Indiana. 
 
Steiner, J.L., & Bigatti, S.M.  (2011). Schema-enmeshment in chronic pain: When self 
and illness are one and the same.  Poster session presented at the annual 2011 
APA convention, Washington, DC. 
 
Steiner, J.L., & Bigatti, S.M.  (2011). Pain acceptance moderates the relationship 
between pain intensity and pain and self-schema enmeshment in fibromyalgia 
patients. Poster session presented at the annual 2011 conference of the Society of 
Behavioral Medicine, Washington, DC. 
 
Steiner, J.L., Ang, D.C., & Chakr, R.  (2010). Anger, catastrophizing and sensitivity to 
pain in fibromyalgia patients.  Poster session presented at the annual 2010 
conference of the Society of Behavioral Medicine, Seattle, Washington. 
 
Bayman, N., Steiner, J.L., & Bigatti, S.M.  (2010). Depressive rumination in cancer 
patients and partners:  Implications for mental health and adjustment to illness. 
Poster session presented at the annual 2010 conference of the Society of 
Behavioral Medicine, Seattle, Washington. 
  
Steiner, J.L., Tallman, E., Miller, K., & Bigatti, S.M.  (2009). Can escape avoidance be 
a good form of coping?.  Poster session presented at the annual 2009 conference 
of the Society of Behavioral Medicine, Montreal, Canada
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Tallman, E., Bigatti, S.M., & Steiner, J.L.  (2009).  Sexual activity and marital 
satisfaction in husbands of women with Fibromyalgia.  Poster session presented 
the annual 2009 conference of the Society of Behavioral Medicine, Montreal, 
Canada. 
 
Teaching Experience 
 
Instructor, IUPUI       8/2011-5/2012 
Courses:  Stress and Health  
Psychology of Women 
Introduction to Psychology as a Social Science  
 
Graduate Teaching Assistant, IUPUI     8/2008-5/2009 
Courses:  Stress and Health 
Introduction to Clinical Psychology 
Capstone in Applied Psychology 
 
Clinical Experience and Training 
 
Predoctoral Internship       7/2012-7/2013 
Salem Veteran Affairs Medical Center 
Salem, VA 
• APA-accredited internship that focused on developing generalist skills  
• Major Rotation Clinical Experiences 
o Behavioral Medicine/Integrated Primary Care 
o Outpatient Psychological Services 
o Substance Abuse Residential Rehabilitation Treatment Program and 
Substance Abuse Liaison Team 
• Minor Rotation Clinical Experiences 
o Palliative Care 
o Chronic Medical Illness Management 
o Military Sexual Trauma 
 
Psychology Practicum      5/2011-11/2011 
Indiana University Neuropsychology Clinic  
Indianapolis, IN   
Supervisor: Daniel Rexroth, Psy.D. 
 
Psychology Practicum      1/2011-5/2011 
LaRue Carter Memorial Hospital  
BASE Unit (Borderline Personality Disorder Unit) 
Indianapolis, IN 
Supervisor: Dr. Joan Farrell, Ph.D. 
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Psychology Practicum       5/2010-12/2010 
St. Vincent Hospital Primary Care Center 
Family Medicine/Internal Medicine 
Indianapolis, IN 
Supervisor: Dr. Thomas Barbera, Ph.D.     
 
Psychology Practicum       8/2009-12/2010 
Telephone-based CBT for chronic pain with Fibromyalgia patients 
IU Clinical Research Center for Pain 
Indianapolis, IN 
Supervisor: Dr. Mark Jensen, Ph.D. 
 
